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SARM (Sterile alpha and armadillo motif- containing protein) is 
evolutionarily conserved and purported to be a TLR (Toll like receptor) 
adaptor. However, macrophage TLR signaling is not affected in SARM 
knockout mouse, indicating that SARM functions independently of 
TLR signaling. Of particular interest is that the SARM expression is 
higher in T lymphocytes than macrophages. Yet, the role of SARM in T 
lymphocytes remains elusive. The exact subcellular localization of 
SARM is still unclear, presenting uncertainties on its functional role(s). 
Here, we demonstrate that mitochondria-localized SARM plays a key 
proapoptotic role to maintain T cell count following the clearance of 
infection. We show that SARM is specifically localized in the 
mitochondria. Using confocal microscopy, transmission electron 
microscopy and subcellular fractionation studies, we demonstrated 
that the N terminal 27 amino acids (S27) of SARM acts as a bona fide 
mitochondria-targeting signal sequence. Importantly, by mutagenesis 
study, we delineated the specificity of the mitochondria-targeting 






Following acute-phase infection, the expanded T cells are terminated to 
achieve immune homeostasis, failure of which results in 
lymphoproliferative and autoimmune diseases. We report that SARM 
is proapoptotic during T-cell contraction. SARM expression is 
significantly reduced in NK/T lymphoma patients compared to healthy 
individuals, suggesting that decreased SARM supports NK/T cell 
proliferation. SARM-knockdown T cells survived longer following 
influenza infection in vivo. During cytotoxic T cell activation, the SARM 
level fell before rising, correlating inversely with T-cell proliferation 
and subsequent clearance. SARM-knockdown rescued T cells from 
both activation- and neglect-induced cell deaths. Mechanistically, 
SARM expression suppresses Bcl-xL and ERK phosphorylation. 
Overexpression of Bcl-xL and double knockout of BAX BAK 
substantially reduced SARM-induced apoptosis. The mitochondria-
localised SARM mediates intrinsic apoptosis by porating mitochondria 
and generating ROS. The proapoptotic function is attributable to the C-
terminal SAM and TIR domains. Importantly Arg14Ala SARM mutant, 
that lacks the mitochondria targeting ability, showed reduced 





mitochondrial localization of SARM is important for its apoptotic 
function. Taken together, this thesis has demonstrated the proapoptotic 
potential of mitochondria-localized SARM, which maintains T cell 
homeostasis. 
 
The immune system is all about balance and control. How the “calm 
after immune signaling storm” occurs is least understood. Our research 
highlights SARM to be an important player involved in restoring the 
system to its normal state via its apoptotic potential. The knowledge 
gained in this study would be essential in our continuing effort to 
develop new and more efficient molecular therapy for 
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1. Introduction                                                                                           
1.1. T cells – the key player of adaptive immunity  
A vast ocean of microbes surrounds humans. Among these infinite 
varieties of microorganisms, relatively few are pathogenic. These 
pathogens cause infection by invading our body tissues and by 
producing toxins. Infectious diseases are a major threat around the 
world, killing millions globally each year (Federal Emergency 
Management Agency). One death in three worldwide is because of 
infectious diseases (WHO and www.ucatlas.ucsd.edu). The immune 
system is the defense mechanism developed in our body to protect us 
from these invading foreign pathogens. Our immune system includes a 
wide repertoire of cells and molecules that function in a much-
coordinated fashion to specifically recognize and eliminate limitless 
varieties of foreign invaders. The two major arms of immune system 
are innate immunity and adaptive immunity. Innate immunity, 
although less specific, forms the frontline defense mechanism. The 
innate immune system’s response to these pathogens is important for 





immune system acts immediately on pathogen entry. Such ability of 
the host is attributable to germ line coded receptors – pattern 
recognition receptors (PRR) that recognize pathogen-associated 
molecular patterns (PAMPs).  
 
The adaptive immune system elicits response to the foreign microbe 
with greater specificity and has a remarkable property called 
“memory”. The adaptive immune system involves harmonized 
response of lymphocytes and antigen presenting cells. Lymphocytes 
arise from the bone marrow and circulate in the blood and lymphatic 
system. These cells express antigen binding cell surface receptors that 
contribute major immunological aspects like specificity, memory and 
self/non self-recognition. The two major populations of lymphocytes 
are B cells and T cells (Figure 1.1). 
 
T lymphocytes arise in the bone marrow and mature in the thymus. 
During maturation, T cells acquire a unique antigen-binding molecule 
on their membrane, called T cell receptors (TCR). They can recognize 





histocompatibilty complex (MHC). MHC molecules that play the 
antigen presentation role are of two types - class I and class II. Nearly 
all the nucleated cells express class I MHC molecule whereas the 
expression of class II MHC is restricted to antigen presenting cells like 
macrophages and dendritic cells. When a naïve T cell recognizes 
antigen presented on the MHC molecule on the cell, the T cell 
proliferates and differentiates into effector T cells and later into 







Figure 1.1: An overview of the T-cell-mediated immunity. T helper cells 
provide help to the cytotoxic T cells and B cells. The cytotoxic T cells are 
involved in the cell-mediated killing of cells, which display foreign antigens. 
The B cells are involved in humoral immunity by secreting antigen specific 
antibodies. Adapted with modification from (Kindt et al., 2007). 
 
T cells are broadly classified into two major groups: T helper (TH) and 
T cytotoxic (TC) cells. TH and TC cells can be distinguished based on the 
cell surface glycoproteins CD4 and CD8. TH, which has the CD4 





on the surface of MHC class II molecules. TC, which bears the CD8 
membrane glycoprotein, can recognize the antigenic peptides 
presented on the surface of the MHC class I molecules (Figure 1.1). 
 
The effector TH cells produce cytokines that help in the activation of B 
cells, TC cells and the macrophages (Abbas et al., 1996; McHeyzer-
Williams et al., 2006). Varied immune responses are produced 
depending upon the cytokine produced by the TH cells.  TC cell in 
response to the antigen MHC class I complex, proliferates and 
differentiates into cytotoxic T lymphocyte (CTL). CTL monitor all the 
cells in the body and eliminate those that display foreign antigens 
(Harty et al., 2000; Wong and Pamer, 2003). Figure 1.1 shows an 
overview of the development and cell mediated immune response 
elicited by T lymphocytes. 
 
1.2. Programmed cell death is essential for T cell development and  
        homeostasis 
Programmed cell death is important for tolerance and homeostasis of T 





reactive and non-responsive T cells. Similarly, after bursts of infection-
induced proliferation, it is necessary to reduce the T cell population to 
appropriate levels to maintain homeostasis. 
 
1.2.1. Apoptosis during T cell development 
T cells get their name from thymus, the organ they mature from. 
Progenitor T cells from the bone marrow migrate to the thymus where 
they undergo two major selection processes to develop into mature T 
cells (Starr et al., 2003). Primarily T lymphocytes undergo three 
developmental stages: the CD4-CD8- double negative stage (DN); the 
CD4+CD8+ double positive stage (DP) and the CD4+CD8- or CD4-CD8+ 
single positive stage (SP) whilst in the thymus. DP thymocytes are 
subjected to positive and negative selection (Figure 1.2). Positive 
selection ensures MHC restriction by allowing the continued existence 
of only those T cells that are capable of recognizing the self-MHC 
molecules. T cells that cannot pass through this selection are 
eliminated by apoptosis. Negative selection expels the T cells that react 
strongly to the self-MHC or with self-MHC plus self-peptide. Negative 





decided by the nature of TCR: MHC-peptide interactions. If the 
resulting signal is of higher strength the cells are destined towards the 
death pathway (negative selection) and if the signal is of intermediate 
strength, then the cells differentiate (positive selection) (Starr et al., 
2003). Figure 1.2 depicts the development of functionally competent T 
cells that are both MHC-restricted and self-tolerant. It is estimated that 
90% of the developing thymocytes die during this selection process 
(Zhang et al., 2005). Two major pathways are reported to mediate 
apoptosis during positive and negative selection. One is via surface 
receptors such as tumor necrosis factor receptor and death receptor 
and the other is via B cell lymphoma-2 (Bcl-2) family members (Starr et 
al., 2003).  
 
B cell lymphoma – extra large (Bcl-xL) is highly expressed in DP 
thymocytes and promotes the life span of DP thymocytes (Motoyama 
et al., 1995). Bim (Bcl-2 interacting mediator of cell death) knockout and 
BAX (Bcl-2 associated X protein) BAK (Bcl-2 homologous antagonist 
killer) double knockout DP thymocytes are also reported to survive 





BAK and BAX that control DP thymocyte survival might participate in 
cell death during the T cell selection process (Bouillet et al., 1999; 
Rathmell et al., 2002). Nevertheless, the detailed mechanism 






                       
Figure 1.2: Apoptosis during T cell development. T cells are educated in the 
thymus, where only the T cells which respond to self-MHC and which do not 
respond to self peptide are selected. The rest of the cells are eliminated by 





1.2.2. Apoptosis during T cell immune response 
After maturation, the naïve T cells migrate to the secondary lymphoid 
organs. The antigen presenting cells present the processed foreign 
antigen to the T cells. T cell activation is then initiated by interaction of 
the TCR-CD3 complex with the processed antigen on the surface of 
MHC molecules. The resting naive T cells enter the cell cycle and 
proliferate extensively. This phase is called clonal expansion and is 
important for the generation of sufficient number of effector T cells 
that are specific to the pathogen. The effector T cells invade the sites of 
infection and inflammation and help in the clearance of the infection. 
After the infection is cleared the effector T cells must be eliminated by 
apoptosis to maintain T cell homeostasis. Hence, only a proportion of 
the clonal T cells remain as memory T cells. Memory T cells respond 
quickly during ensuing exposure to the same antigen. Memory T cells 
are reported to be resistant to apoptosis that occurs during T cell 
clearance (Gronski and Weinem, 2006; Konig et al., 2002; Pinkoski and 






Effector T cells are highly proliferative and hence there should be an 
efficient way to control their lifespan in order to maintain lymphocyte 
homeostasis. Programmed cell death helps to decline the lymphocyte 
numbers during the contraction phase of an immune response. Effector 
T cells that are apoptosis resistant in the expansion phase gradually 
shift to become apoptosis sensitive in the contraction phase. Decreased 
cell death of activated lymphocytes can result in autoimmune 
disorders. On the other hand increased cell death can lead to 
immunodeficiency. Hence, several molecular players like cytokines, 
death receptors, mitochondria and Bcl-2 family, NF-B (Nuclear factor 
kappa light chain enhancer of activated B cells), MAPK (Mitogen 
activated protein kinase) and hematopoietic progenitor kinase are 
involved in deciding the “Life or death decision of T cells”. Two 
distinct forms of cell death clear the activated T cells:  
1. neglect-induced cell death (NID) or activated cell 
autonomous cell death (ACAD)  
2. activation-induced cell death AICD (Arnold et al., 2006; 
Brenner et al., 2008; Krammer et al., 2007) 





              
  
 
Figure 1.3: Schematic representation of apoptotic phenotype of T cells 
during immune response. On antigen challenge, T cells are activated and 
they proliferate extensively. During the early phase of T cell activation, the 
cells are resistant to apoptosis. After peak response, the T cells become more 
sensitive to apoptosis and T cell numbers decline during the contraction 
phase. NID and AICD are the two major cell death pathways during T cell 
contraction. Adapted from (Brenner et al., 2008) with modification. 
 
AICD is induced by restimulation of the T cell receptors of the 
activated T cells. AICD mainly depend on death receptor engagement 
and hence it occurs primarily via the extrinsic cell death pathway. In 





pathway via mitochondria (Arnold et al., 2006; Brenner et al., 2008; 
Krammer et al., 2007).  
 
NID is commonly referred as death by neglect, death by cytokine 
withdrawal or passive cell death. As the terms reflect, NID is mainly due 
to the deprivation of survival factors like IL-2 (Interleukin -2) and other 
cytokines, which leads to cell death. Bcl-2 family members primarily 
mediate this form of cell death. The antiapoptotic Bcl-2 family 
members - Bcl-2 and Bcl-xL are well regulated during different stages 
of T cell immune response. Bcl-xL is upregulated in proliferating 
activated T cells (Boise et al., 2010; Lee et al., 2002; Rogers et al., 2001; 
Watts, 2010). Importantly, the memory T cells that are not deleted 
during T cell contraction show higher levels of Bcl-2 and Bcl-xL 
(Grayson et al., 2000) (Garcia et al., 1999). Other Bcl-2 family members, 
Bcl-2 and Mcl-1, are reported to maintain the peripheral T cell 
population (Dunkle et al., 2010; Dzhagalov et al., 2008; Wojciechowski 






The sensitization of T cells to AICD depends on the cytokine, IL-2. 
Although, IL-2 is important for T cell survival, it is also required for 
sensitizing the cells towards AICD. The sensitization to AICD is lost in 
IL-2 deficient or IL-2R deficient mice (Lenardo, 1991; Refaeli et al., 
1998; Willerford et al., 1995). IL-2 is reported to be important for the 
increased expression of FAS and FASL (Death receptor and Death 
receptor ligand) and decreased expression of anti-apoptotic molecule, 
c-FLIP (cellular- Caspase-8 (FLICE)- like inhibitory protein) (Refaeli et 
al., 1998). The upregulation of FAS and FASL increases the sensitivity 
of the cells to undergo extrinsic cell death. Apart from IL-2, the 
cytokines that have a positive effect on the sensitization to AICD are 
IL-4 and IFN- (Interferon-) (Refaeli et al., 2002; Zhang et al., 2003). 
However, IL-15 is reported to block T cell death mediated by IL-2 and 
it contributes to the propagation of memory T cells (Marks-Konczalik 
et al., 2000). Although, AICD and ACAD are two different pathways 
they converge upon the activation of caspases, which execute 
apoptosis. Thus, the execution of apoptosis leads to successful 





AICD and ACAD are being examined, the molecular players involved 
in these processes are still not fully characterized. 
 
1.3. Clinical implications of impaired homeostasis of the T cell  
        population 
Apoptosis is a key mechanism to maintain T cell homeostasis. If the 
apoptotic machinery fails, the T cells become abundant and cancer 
ensues. On the other hand, excessive apoptosis will deplete the T cells 
and result in immunodeficiency. Failure in apoptosis of activated T 
cells impairs lymphocyte homeostasis, leading to autoimmunity and 
lymphoproliferative diseases (Bidere et al., 2006). The importance of 
apoptosis is clearly demonstrated using lpr/lpr mice 
(lymphoproliferation) (Gillette-Ferguson and Sidman, 1994; Watanabe-
Fukunaga et al., 1992). Lpr/lpr mice have non-functional FAS. Hence, 
when the T cells are activated in these mice, the T cells continue to 
proliferate, and maintain in the activated state. The mice 
spontaneously develop autoimmune disease and have excessive 
numbers of T cells. Correspondingly, gld/gld mice (generalized 





similar abnormalities as lpr/lpr mice (Gillette-Ferguson and Sidman, 
1994).  Similarly, BAX-/-BAK-/- chimera mice develop splenomegaly and 
lymphadenopathy as the T cells are resistant to cell death (Rathmell et 
al., 2002). Humans with mutated FAS/FASL suffer from similar 
autoimmune and lymphoproliferative diseases (Nagata, 1998). 
Autoimmune lymphoproliferative syndrome (ALPS) is the inherited 
genetic disorder in humans that arise due to defective FAS gene. Such 
patients are reported to suffer from Canale Smith Syndrome, exhibiting 
lymphadenopathy and splenomegaly (Drappa et al., 1996). Chronic 
enlargement of the lymph nodes, spleen, thymus and liver is mainly 
due to the accumulation of lymphocytes that failed to undergo normal 
programmed cell death. Unlike normal single positive T cells (either 
CD4+ or CD8+), these peripheral expanded T cells are characterized to 
be double negative (CD4- and CD8-) (Figure 1.4). These Double 
Negative T cells (DNTs) could be from previously activated mature T 
cells that have lost CD8 or CD4 co-receptor. DNTs are the major 






Molecular characterization of FAS genes in ALPS patients identified 
mutation in or around the death domain of the gene. Evidences 
indicate that patients with decreased FAS function also suffer from 
ALPS-like clinical syndrome and it is termed as ALD (Autoimmune 
Lymphoproliferative Disease) (Ramenghi et al., 2000). Like ALPS, ALD 
is also a genetic disorder. ALPS is also reported to occur due to 
mutation in FASL and Caspase-10 (Rieux-Laucat et al., 2003; Wang et al., 
1999). There are some cases of ALPS, with an unknown molecular 
pathogenesis. All these data collectively suggest the severity of the 
failure in T cell contraction by apoptosis. 
        
Figure 1.4: Proportion of DNTs in ALPS patients. T cells isolated from ALPS 
patient/healthy individual are double stained with T cell receptors CD8 and 
CD4. The cells were then analyzed by flow cytometry. It is evident that T cells 
from ALPS patients are mainly double negative T cells (DNT) when 
compared to healthy subjects. Adapted from (Drappa et al., 1996; 





Nonetheless of difference in molecular pathogenesis, the development 
of lymphoma has been repeatedly reported in several clinical cases of 
ALPS and ALD (Straus et al., 2001). Hence, in our study we used 
tissues from one such kind of Non-Hodgkin’s lymphoma called NK/T 
cell lymphoma.  
 
1.3.1. NK/T cell lymphoma 
Non-Hodgkin’s lymphoma is the seventh most common cancer and 
the sixth highest cause of cancer deaths (http://www.lls.org). 
Extranodal nasal NK/T cell lymphoma is one such clinically aggressive 
tumor most commonly affecting Asians and Central and South 
Americans. It is caused by the proliferation of either cytotoxic T cells or 
NK cells (Natural killer cells) with a cytotoxic phenotype. Malignant 
lymphocytes proliferate uncontrollably and amass in lymph nodes, 
spleen and other sites in the body. The malignancies are mainly found 
in the nasal and paranasal sinus region outside of the traditional 
lymph node groupings and hence it is termed as extranodal NK/T cell 
lymphoma. Epstein Barr Virus is detected in the neoplastic cells in a 





pathogenesis. The nasal NK/T-cell lymphoma frequently presents with 
necrotic, agranulomatous lesions in the upper respiratory tract. The 
pathogenesis involves either mutation or altered gene expression of 
well-known tumor suppressors and oncogenes (Aozasa et al., 2008; 
Huang et al., 2010; Ng et al., 2011). For examples, some NK/T cell 
lymphoma clinical samples bear mutations in FAS and p53, leading to 
the development of the tumor. Gene expression profiling and 
immunohistochemistry of formalin-fixed paraffin embedded (FFPE) 
NK/T cell lymphoma tissue, in comparison with normal NK cells, 
revealed a significant enrichment of c-Myc, p53, NF-B p50 and 
survivin demonstrating the proliferative and antiapoptotic phenotype 
in NK/T cell lymphoma.  
 
1.4. Programmed cell death - Apoptosis 
Apoptosis is the most sophisticated pathway that is identified in the 
cells so far. The apoptotic machinery is conserved from nematodes to 
mammals. Apoptosis is important for various processes like 
development, ageing, homeostasis of cell population in the tissue, and 





dependent process that involves a family of cysteine proteases called 
“caspases”. Apoptosis is also a crucial mechanism of immune defense. 
It prevents excessive inflammation, limits the spread of microbial 
invaders, and initiates adaptive immune response (Elmore, 2007; 
Winau et al., 2005). As discussed above, apoptosis is vital for T cell 
development and maintenance. There are two major pathways in 
apoptosis – Extrinsic and Intrinsic. 
 
1.4.1. Extrinsic apoptotic pathway 
The extrinsic apoptotic pathway, as the name suggests, begins outside 
the cell through the activation of cell surface death receptors by ligands 
like CD95 ligand (FASL), tumor-necrosis factor and TNF-related 
apoptosis-inducing ligand (TRAIL). There are several death receptors 
namely: CD95 (FAS), TNF receptor (TNFR), TRAIL receptor-1 
(TRAILR1), TRAILR2, death receptor 3 (DR3) and DR6 (Ashkenazi and 
Dixit, 1998). All these death receptors possess similar cysteine-rich 
extracellular domain and cytoplasmic domain (about 80 amino acids) 





death signal from the cell surface to the intracellular signaling 
pathways.   
 
The apoptotic signal is transduced by the formation of a large 
intracellular protein complex at the cell membrane. Activation of FAS 
by FASL recruits several cytoplasmic proteins leading to the formation 
of FAS DISC (death-inducing signaling complex) (Kischkel et al., 1995). 
DISC formation is mediated through cascade of several homotypic 
interactions between four major proteins namely – FAS (CD95), FAS-
associated death domain (FADD), two isoforms of procaspase-8 and 
procaspase-10. DD of FAS interacts with DD of FADD. Death effector 
domain (DED) of FADD interacts with DED of procaspase-8, 
procaspase-10 and c-FLIP. Thus, DISC assembly brings the procaspase-
8 and procaspase-10 in close proximity to each other leading to auto 
proteolytic activation (Chang et al., 2003; Muzio et al., 1998). Caspase-8 
and Caspase-10 are the initiator caspases of extrinsic apoptotic 
pathway. Thus, active caspase-8 and caspase-10 are released in the 
cytosol to trigger the execution phase of apoptotic process. Death 





FADD and caspase-8, rendering them ineffective (Bentele et al., 2004; 
Lavrik and Krammer, 2012). Figure 1.5 is the schematic representation 
of extrinsic cell death pathway. 
 
 
Figure 1.5: Extrinsic apoptotic pathway mediated by death receptors on the 
cell surface (adapted from Genentech, http://www.biooncology.com). DISC 
formation by the activation of death receptor leads to the activation of the 





1.4.2. Mitochondria mediated intrinsic apoptotic pathway  
Intrinsic apoptosis arises from the intracellular cell signal rather than 
receptor mediated signaling. Intrinsic apoptosis largely depends on the 
permeabilization of the outer membrane of mitochondria (Kroemer et 
al., 2007). The signal that activates intrinsic apoptosis involves 
withdrawal of factors, namely certain growth factors, hormones and 
cytokines that are important for the suppression of apoptosis. 
Conditions like radiation, viral infection, free radicals, toxins and 
hypoxia also induce intrinsic apoptosis (Elmore, 2007). All these 
stimuli lead to the opening of the mitochondrial permeability 
transition pore (MPTP) leading to the loss of the mitochondrial 
transmembrane potential (m). Mitochondrion is not only termed as 
“the power house of the cell”, it is also a “cellular poison cupboard”. 
Thus, MPTP formation is followed by the release of two main groups 
of proapoptotic proteins that are sequestered in the intermembrane 
space of the mitochondria into the cytosol (Saelens et al., 2004). Thus 
the mitochondria irreversibly commit the cells to apoptosis via three 
general interrelated mechanisms;  





2. release of mitochondrial proteins that activate caspases 
and  
3. alteration of the redox balance of cells 
The first group of proteins that are released consists of cytochrome c, 
Smac (Second mitochondria-derived activator of caspases)/DIABLO 
(direct IAP binding protein with low pI) and HtrA2 (High temperature 
requirement protein A2)/Omi (Du et al., 2000; Garrido et al., 2006; van 
Loo et al., 2002). Cytochrome c is a key component of the electron 
transport chain in the mitochondria, but upon release in the cytoplasm 
it binds with apoptosis protease activating factor 1 (APAF1) leading to 
the formation of apoptosomes. (Hill et al., 2004). The initiator, pro-
caspase-9, is recruited by the interaction of its caspase recruitment 
domain (CARD) with that of APAF1. Figure 1.6 shows the activation of 
caspase-9 by apoptosome formed by cytochrome c and APAF1. 
Caspase-9 is thus activated and in turn, activates the effector caspases -
3, -6 and -7.  Smac/DIABLO and HtrA2/Omi promote apoptosis by 
inhibiting IAP (inhibitors of apoptosis proteins) (Du et al., 2000; van 





The second group of proapoptotic proteins – Apoptosis inducing factor 
(AIF), endonuclease G (EndoG) and caspase activated DNase (CAD) 
are released after the cell has been committed to die. All these proteins 
translocate into the nucleus and cause DNA fragmentation and 
condensation of the nuclear chromatin (Enari et al., 1998; Joza et al., 
2001; Li et al., 2001; Susin et al., 2000). AIF and EndoG act in a caspase-
independent fashion. However, CAD is activated by caspase-3 






Figure 1.6: Apoptosome formation due to the release of cytochrome c from 
the mitochondria. In healthy cells cytochrome c is retained inside the 
mitochondria and APAF1 exist in the cytosol in an inactive form. Cytochrome 
c that is released from the mitochondria in response to various stimuli binds 
to APAF1 and lead to apoptosome formation. This process is energy 
dependent and lead to the activation of caspase-9. Adapted from 
(Ledgerwood and Morison, 2009). 
 
1.4.3. Bcl-2 family members and mitochondrial integrity  
Bcl-2 family of proteins primarily guards the integrity of mitochondria 





or antiapoptotic. Bcl-2 family comprises of three major groups of 
proteins – antiapoptotic Bcl-2-like proteins (Bcl-2, Bcl-xL, Mcl-1, Bcl-w 
and A1/Bfl-1), proapoptotic Bax-like proteins (BAX, BAK) and 
proapoptotic BH3 only proteins (Bid, Bim, Bad, Bik, Noxa and Puma). 
Except for the BH3 only protein, the first two groups have four Bcl-2 
homology (BH) domains (Martinou and Youle, 2011). 
 
In a viable cell, BAX is mainly a cytosolic monomer and is observed to 
traverse back and forth the mitochondrial outer membrane (MOM). 
Once BAX is attached to the outer membrane, it is retranslocated to the 
cytosol by the anti-apoptotic Bcl-xL via a mechanism that is not yet 
fully understood (Edlich et al., 2011). This translocation of BAX 
prevents its accumulation in the outer mitochondrial membrane 
(OMM) to reach a critical level that might lead to the mitochondrial 
outer membrane permeabilization (MOMP). Figure 1.7 depicts the 







Figure 1.7: Interaction between BAX and Bcl-xL in healthy cells. In healthy 
cells BAX moves back and forth the cytosol to the mitochondrial outer 
membrane. Interaction with Bcl-xL prevents BAX from oligomerizing on the 
mitochondrial outer membrane. 
 
The BH3-only protein, tBid (truncated BH3 interacting-domain death 
agonist) is reported to induce conformational change to the BAX N 
terminus to mediate BAX insertion and oligomerization in the OMM 
(Eskes et al., 2000). A similar mechanism was reported for other BH3–
only proteins, including Bim and Puma (p53 upregulated modulator of 
apoptosis) (Gallenne et al., 2009; Kim et al., 2009; Kuwana et al., 2002; 





triggering of apoptosis, the anti-apoptotic Bcl-2 members, Bcl-2, Bcl-xL 
and Mcl-2, sequester activators BH3 in the inert state to suppress 
BAX/BAK activation (Cheng et al., 2001; Werner et al., 2002). It is also 
reported that the BH3 - helical mimetics disrupts the protein-protein 
interaction between antiapoptotic and proapoptotic proteins, leading 
to BAX- and Bim- dependent apoptosis (Kazi et al., 2011). Hence, it is 
the regulation between the pro- and anti-apoptotic members of Bcl-2 
family that governs the induction of intrinsic apoptosis. 
    
  
Figure 1.8: Schematic representation of activation of BAX and BAD by 
activator BH3 only proteins. The activators BH3s, tBID/BIM/PUMA attack 
and expose the 1 helix of BAX. This results in the secondary disengagement 
of the 6 helix of BAX, resulting in mitochondrial insertion. Oligomerization 
of BAX/BAK results in MOMP formation. Adapted from (Kim et al., 2009).  
 
 
Caspase-8, an initiator caspase of the extrinsic apoptosis pathway, is 





al., 1998) highlighting the cross talk between the two pathways. The 
two major routes of apoptosis converge at the effector caspases 
(Caspases-3 and -7). The effector caspases activate cytoplasmic 
endonucleases and proteases leading to the degradation of nuclear 
materials and cytoskeletal proteins. This ultimately accounts for the 
morphological and biochemical changes seen in apoptotic cells (Slee et 
al., 2001).  
 
1.5. Toll-like receptors  
TLRs are a major class of Pathogen Recognition Receptors (PRRs). TLRs 
are initially discovered in the Drosophila and are reported to be 
involved in antifungal response (Imler and Hoffmann, 2001). To date, a 
total of 13 TLRs have been identified in mammals (Takeda and Akira, 
2007).  
 
The TLRs are either located on the host cell surface to differentially 
recognize the extracellular pathogens or on the endosomal surface to 
recognize the intracellular pathogens. The TLRs, either homo- or 





molecular patterns (PAMPs) that are uniquely displayed on the 
pathogen surface, and then, transduce the signal into the host immune 
cell. Figure 1.9 depicts a brief overview of the location of the various 
TLRs and also the PAMPs they recognize.  
 
 
Figure 1.9: Toll like receptors. Schematic representation of different TLRs, 
their localization and the PAMPs, which they recognize. Adapted from (Kindt 
et al., 2007). 
 
Upon recognition of PAMPs, the TLRs trigger intracellular signaling 
leading to the activation of transcription factors like NF-B, AP-1 





activate immune-related genes (Figure 1.10), and consequently, the 
expression and synthesis of pro inflammatory cytokines and 




Figure 1.10: TLR signaling. The stimulation of TLRs lead to the activation of 
the transcription factors NF-B, AP-1 and IRF3. These transcription factors 
signal for the production of inflammatory cytokines like IL-8, IFN-β and IP-
10. Adapted from (Duez et al., 2006). 
1.5.1. Diverse signaling pathways induced by TLR activation 
TLR signaling is crucial not only during early innate immune response, 





and Jungi, 2003). Upon infection, the antigen presenting cells like 
macrophages and dendritic cells, which express TLR on their surfaces, 
bind PAMP and initiate the signaling pathway and activate the 
adaptive immunity (Medzhitov, 2001) (Figure 1.11). TLRs are also 
expressed on T cells, and TLR agonists can directly activate them. TLR 
stimulation of T cells has a co-stimulatory capacity during the initiation 
of adaptive immunity (Gelman et al., 2004; Komai-Koma et al., 2004).  
       
Figure 1.11: Role of TLRs during initiation of adaptive immunity. TLR 
signaling in antigen presenting cells, upregulates cell-surface expression of 
co-stimulatory molecules (CD80 and CD86) and MHC class II molecules. 
TLRs also induce the expression of cytokines that are important for dendritic 





Recent studies have shown that TLR signaling also induces apoptosis 
(Salaun et al., 2007). Seven out of 10 human TLRs are shown to induce 
apoptosis. Global expression profiling of the genes on TLR signaling 
showed that apart from the “Inflammatory and Pro-survival genes”, 
several genes involved in “apoptosis” are also upregulated (Eldering et 
al., 2003). Cell death is also a mechanism of innate immune defense. 
Cell death protects the host by limiting the spread of invading 
microbes. Apoptosis is considered to be a tactic to confine the 
pathogens at the site of infection (Salaun et al., 2007). Hypersensitive 
response – programmed cell death in plant cell is a major immune 
defense strategy (Lam et al., 2001). Thus, it appears that TLR activation 
can engage diverse signaling pathways. Therefore, deep insights into 
the regulation of TLR signaling are crucial to provide the molecular 
basis for preventing and treating infectious diseases under tightly 
regulated conditions to ensure a fine balance between immune 








1.5.2. Cytosolic mediators of TLR signaling: TLR Adaptors  
TLRs trigger the intracellular signaling via five different adaptor 
proteins: MyD88 (Myeloid differentiation primary response gene 88), 
Mal (MyD88- adaptor –like protein), TRIF (TIR-domain-containing 
adaptor molecule), TRAM (TRIF related adaptor molecule) and SARM 
(Sterile alpha and armadillo-motif-containing protein). All the adaptor 
proteins have a TIR domain, which mediates the TIR-TIR homotypic 
interactions leading to the downstream TLR signaling. Figure 1.12 
shows the domain architecture of all the TLR adaptors (Watters et al., 
2007).  
 
The differential recruitment of TLR adaptors to the TLRs provides 
specificity to the signaling pathway. Based on the adaptors recruited, 
the TLR signaling is mainly classified into two pathways: (1) MyD88-
dependent and (2) TRIF-dependent. The TRIF-dependent signaling is 
involved in the delayed activation of NF-B (Beutler, 2004). All TLRs 
except for TLR3 recruit MyD88 to mediate immune signaling (Kagan et 
al., 2008; Xu et al., 2000). Both TLR2 and TLR4 require Mal to recruit 





TRIF interacts with TLR4 via TRAM (Bin et al., 2003; Fitzgerald et al., 
2003; Yamamoto et al., 2003). All the TLR adaptors except for SARM are 
found to positively regulate the TLR signaling. 
  
 
Figure 1.12: Domain architecture of four major TLR adaptors. All the four 




1.5.3. SARM, the multi-domain TLR adaptor 
SARM (Sterile Alpha and Armadillo motif containing protein) is the 
recently identified fifth TLR adaptor member. SARM has a very unique 
domain architecture containing three different domains; two ARM 





Interestingly, all the three domains in SARM play a role in mediating 
protein-protein interaction. Figure 1.13 shows the domain architecture 
and demarcations of the functional domains of SARM. 
 
Figure 1.13: Domains of SARM. (A) The exact location of various domains of 
SARM. ARM – Armadillo repeat motif, SAM – Sterile Alpha Motif and TIR- 
Toll /Interleukin I Receptor like domain. (B) Amino acid sequence of human 
SARM. The ARM, SAM and TIR domains are indicated by lines below each of 
the domains.  
 
The ARM motif is found in proteins from a wide variety of eukaryotes 





motif is characterized by the tandem repeats of a conserved 42 amino 
acid–long sequence, as seen in the -catenin (Peifer et al., 1994) (Figure 
1.14). These repeats fold into three alpha helices. Bundles of helices of 
the multiple repeats composing the ARM motif in turn, fold further, 
creating a regular structure of the right-handed superhelix (Coates, 
2003).  
 
Proteins containing ARM repeats display diverse functions including 
regulation of cytoskeleton, transportation of proteins between the 
cytosol and the nucleus, acting as the guanine nucleotide exchange 
factor, controlling gene expression and signaling. The versatile 
functions of the ARM repeat domain-containing proteins are 
Figure 1.14: Crystal structure of the ARM 
motif of -catenin. The ARM domain of -






attributable to the super helical structure of the ARM motif, which 
provides surface area for multiple protein interactions.  
 
The SAM is a conserved domain constituting approximately 70 amino 
acids (Ponting, 1995). SAM is present in almost 1000 proteins from a 
wide variety of eukaryotes and even some bacteria (Schultz et al., 1997). 
The functions of SAM-harboring proteins are extremely diverse, 
ranging from transcriptional translational regulation, apoptosis to 
signal transduction (Kim and Bowie, 2003). 
 
The TIR domain is highly conserved, being found in three protein 
families that play a role in immune response, namely, IL-1 receptor 
family, TLR family, and TLR adaptor family. It is the presence of the 
TIR domain that group SARM under TLR adaptor family. Interactions 
between the TIR domains of TLRs or between the TLR-TIR and the 
downstream adaptor-TIR are critical for the elucidation of innate 
immune response. Within the TIR domain, there are three highly 
conserved regions, named box 1, box 2 and box 3. These regions play a 





two different proteins. The sequence similarity between different TIR 
domains is generally, 20-30% (O'Neill et al., 2003). This suggests that 
there is a significant structural uniqueness among various TIR domains, 
which contributes to the specificity to different pathogens/PAMPs, and 
in activating the different signaling pathways. 
 
1.5.3.1. SARM functions uniquely from other TLR adaptors 
Of all the TLR adaptors, SARM is least characterized, and yet, it is the 
SARM homologues, which are most well conserved, from worm to 
human. The homologues of mammalian SARM have been described in 
Drosophila (Mink et al., 2001), Zebra fish (Jault et al., 2004; Meijer et al., 
2004), C. elegans (Couillault et al., 2004), Horseshoe crab (Belinda et al., 
2008) and Porcine (Zhou et al., 2012). Phylogenetic analysis indicated 
several hundred million years of evolutionary conservation of SARM, 
suggesting its fundamental significance and biological relevance 
(Figure 1.15). Recently, SARM is reported to be closely related to 
bacterial proteins with TIR domain (Zhang et al., 2011). Although, 
SARM cDNA was originally isolated from the brain, in the study by 





and liver. They also showed the presence of SARM antisense transcript 
in kidney and liver (Mink et al., 2001), suggesting the possible 
mechanisms involved in SARM regulation. In contrast to this, Kim et al 
showed that SARM is highly expressed in the brain, T and B cells. 
Unlike other TLR adaptors, SARM is not detected in both human and 
mouse myeloid cells (the cell type that plays a major role in TLR 
signaling). Studies using transgenic SARM reporter mice confirmed the 
absence of SARM in CD11 macrophages (Kim et al., 2007). Co-
immunoprecipitation studies of human retinal membrane extract on an 
anti-retinoschisin immunoaffinity matrix indicated retinoschisin 
interacts with SARM. Retinoschisin plays a crucial role in the cellular 
organization of the retina, and mutations in this gene are responsible 
from X-linked retinochisis (macular degeneration). It is hypothesized 
that interaction of retinoschisin with SARM may be a part of a novel 
SARM-mediated cell signaling pathway required for the maintenance 
of retinal cell organization (Molday et al., 2007). Importantly, this study 
indicates the presence of SARM in retinal cells. Such reports on 
different spatial distributions of the SARM gene expression imply 





             
 
Figure 1.15: SARM is evolutionarily conserved. ClustalX performed 
multiple sequence alignment for various SARM homologues. Rooted 
phylogram was drawn for various SARM homologues by neighbor-joining 
algorithm and visualized by Njplot with >10000 bootstrap. Branch lengths are 
proportional to sequence divergence and can be measured relative to the 





SARM, being reported as TLR adaptor, is considered to be present as a 
soluble cytoplasmic protein. Kim et al reported that SARM is associated 
with the outer membrane of mitochondria and highlighted that SARM 
lacks the mitochondria-targeting sequence and is not localized in the 
mitochondria (Kim et al., 2007). Furthermore, Peng et al showed that 
SARM is localized in the cytoplasm with a dot-like pattern in the 
nucleus and claimed that it is anchored to the intracellular membrane 
(Peng et al., 2009). Hence, the exact subcellular localization of SARM is 
unclear, although its precise identification will offer insights into its 
functional role. In our current study, we have delineated the exact 
subcellular localization of SARM and also characterized the critical 
signaling element. 
 
The C. elegans ortholog of SARM, the TIR-1, was reported to upregulate 
worm immunity. The knockdown of TIR-1 by RNAi resulted in 
decreased worm survival when under fungal and bacterial infection 
(Couillault et al., 2004; Liberati et al., 2004). Importantly, this function of 
TIR-1 is independent of single nematode Toll-like receptor (Couillault et 





the TLR signaling. The human SARM (hSARM) adaptor was identified 
as a negative regulator of TRIF-dependent NF-B activation and both 
TRIF- and MyD88-dependent AP-1 activation (Carty et al., 2006; Peng et 
al., 2009). The horseshoe crab (C. rotundicauda) CrSARM, was also found 
to downregulate the TLR signaling. This suggests the conservation of 
SARM function from horseshoe crab to human (Belinda et al., 2008). 
Amphioxus and porcine SARM is also reported to function as a 
negative regulator of TLR signaling (Yuan et al., 2010; Zhou et al., 2012). 
However, macrophages from SARM knockout mice produced similar 
levels of TNF and MCP-1 as the wild type cells in response to LPS, poly 
(I:C), Pam3Cys and CpG (TLR agonists). Thus, in mouse, SARM does 
not regulate macrophage TLR signaling (Kim et al., 2007). Consistently, 
another study using primary macrophages and dendritic cells from 
independently generated SARM knockout mice also reported no defect 
in response to TLR stimuli (Szretter et al., 2009). Thus, it appears that 
SARM functions differently from other TLR adaptors. 
 
Apart from the TLR signaling, several prime functions of SARM in 





reported to be involved in the neuronal development via MAPKKK 
signaling pathway (Chuang and Bargmann, 2005). SARM is also shown 
to regulate physiological response to pathogenic and nutritional 
bacteria in C. elegans (Shivers et al., 2009). SARM is important for the 
dendritic arboration of neurons probably by stabilizing microtubules 
(Chen et al., 2011).  In C. elegans, SARM regulates anoxic cell death 
(Hayakawa et al., 2011). In the brain, SARM is found to mediate the 
stress-induced neuronal toxicity (Kim et al., 2007). In many of the above 
stated study SARM mediates its action via MAPK signaling pathway 
both in worm and human (Hayakawa et al., 2011; Kim et al., 2007; 
Liberati et al., 2004; Shivers et al., 2009). Thus, SARM appears to play 
diverse functional roles. Besides the neurons, SARM is mainly 
expressed in T lymphocytes. However, the significance of SARM 
expression in T cells has not yet been tested. In this study, we have 
specifically focused on the functional importance of SARM in T 
lymphocytes. 
 




2. Hypothesis, rationale and specific aims of the study                                                                                                    
Based on the published reports and preliminary results from our lab, 
the following observations are made:  
1. TIR-1, the C. elegans SARM homologue is important for 
mediating anoxic death (Hayakawa et al., 2011).  
2. Mouse SARM is involved in stress-induced apoptosis in 
neuronal cell as indicated in SARM knockout mice (Kim et al., 
2007). 
3. Presence of twice the number of cells in the lymph nodes of 
SARM knockout mice when compared to wild type (courtesy 
Prof. Aihao Ding, Cornell). 
4. Global gene expression profiling of NK/T cell lymphoma 
compared to normal NK cells indicate that SARM is 
downregulated in apoptosis resistant lymphoma tissue (Ng et al., 
2011). 
5. SARM expression is attenuated on activation-induced T cell 
proliferation, based on our preliminary observation. 
 




Based on these observations and literature information, we hypothesize 
that SARM activates the apoptotic signal to maintain the T cell count 
following the clearance of the pathogen. Figure 2.1 is the graphical 
representation, which outlines the intended hypothesis. 
The following specific aims are designed to study and validate the 
proapoptotic potential of SARM during T cell contraction. Experiments 
are structured to study the apoptotic pathway mediated by SARM and 
the subcellular localization of SARM enabling its proapoptotic function 
(Figure 2.2). 
1. To determine and characterize the exact subcellular localization 
of SARM aiding its proapoptotic potential. 
2. To decipher the detailed mechanism of SARM induced apoptosis 
using HEK 293T model cell line and primary cytotoxic T cells. 
3. To examine the pathophysiological significance of SARM’s 
apoptotic potential during in vivo influenza infection and in 
clinical lymphoma biopsy samples. 
 






Figure 2.1: Diagrammatic representation of the intended hypothesis. The T 
cells immune response is shown with the cell counts at each stage. Following 
the pathogen clearance, the expanded clonal T cell population should be 
cleared and only a proportion of the T cells continue to stay as memory T 
cells. Thus, homeostasis is achieved. Any defect in the immune deactivation 
mechanism might result in lymphoma. We speculate that SARM induces 
apoptosis to bring down the T cell numbers following T cell immune 
response.    
 
 





Figure 2.2: Overview of the three specific aims designed to test the 
hypothesis. 
 
2.1. Rationale for the choice of experimental model systems  
The choice of cell lines, mice, and experimental design are intended to 
provide a comprehensive assessment of SARM-induced apoptosis in T 
cells during infection and also to validate SARM-induced apoptosis 
during infection. The following pages describe various model systems 
that are employed in our study. 
 




2.1.1. OTI+RAG-/- mice (C57BL/6J) 
OTI+RAG-/- mice model has a transgene that encodes for the T cell 
receptor specific for chicken ovalbumin 257 – 264 (SIINFEKL) presented 
by MHC class I molecule (Hogquist et al., 1994). It is also deficient of 
RAG gene and hence, will not develop mature T cells or B cells with the 
endogenous receptor. Thus, all the peripheral T cells expressed in this 
strain are mostly cytotoxic T (CD8 T) cells that express the transgene. 
Hence, lymph node from this mouse is the homogenous source of CD8 
T cells (Figure 2.3). In this project, the lymph nodes obtained from the 
OTI+RAG-/- strain will be used to study the role of SARM in the 
cytotoxic T cells. 
 
Figure 2.3: Purity of the CD8 T cells obtained from lymph nodes of OTI+ 
RAG-/- mice. Lymph node cells from OTI+ RAG-/- were stained with anti-CD8 
APC and anti-CD3 PE to examine the purity of cytotoxic T cells (CD8).  




2.1.2. Thy1.1 mice (B6.PL-Thy1a/CyJ) 
Thy1.1 congenic strain carries a T lymphocyte specific Thy1a (Thy1.1) 
allele in contrast to the wildtype C57BL/6J strain that express Thy1b 
(Thy1.2) allele. The Thy1.1 congenic strain was generated in Jackson 
laboratory by backcrossing Thy1a expressing PL/J onto C57BL/6J. Thy1.1 
mice are used in our adoptive transfer experiments.  In adoptive 
transfer experiment donor T cells (Thy 1.2 cells) can be easily 
distinguished from the recipient T cells by flow cytometry using Thy1.2 
specific antibody.  
 
2.1.3. Human Embryonic Kidney HEK 293T 
Human Embryonic Kidney 293 cell line was generated by transforming 
the normal human embryonic kidney cells with sheared adenovirus 5 
DNA (Graham, 1977). The HEK cells were obtained from a healthy 
aborted fetus. HEK 293T is a highly transfectable derivative of the HEK 
293 cell line. There are evidence that HEK 293 cells show some 
phenotypes similar to that of the established neuronal lineage cell lines 
such as PC12 and Ntera-2 cells (Shaw, 2002). SARM is expressed in both 




kidney and neurons. Hence, we used HEK 293T as a model cell line to 
study the functional role of SARM.  
 
2.1.4. Recombinant influenza A virus - WSN-SIINFEKL 
         
Figure 2.4: Schematic representation of the WSN-SIINFEKL Influenza A 
virus. The CD8 epitope SIINFEKL is integrated into the neuraminidase (NA) 
gene of WSN Influenza virus. The red circles represent the integrated 
SIINFEKL peptides that are expressed together with the neuraminidase 
protein on the virus surface.    
 
WSN-SIINFEKL virus was generated by reverse genetics. This virus 
was generated by co-transfecting 12 plasmids that encode all the viral 




elements into MDCK cell. The independent plaques were isolated and 
sequenced to confirm successful recombination. Neuraminidase gene of 
WSN virus was modified by site-directed mutagenesis to insert 24 
nucleotides that encode 8 amino acid residues (SIINFEKL) near the 
neuraminidase stalk (Topham et al., 2001) (Figure 2.4). WSN-SIINFEKL 
virus is used to trigger immune response of OTI CD8 T cells that 
possess TCR specific for SIINFEKL.  
 
2.1.5. In vivo adoptive transfer influenza infection mouse model  
We have developed a new and relevant mouse model to study the 
effect of SARM knockdown in T cells during influenza infection. The 
motivation for innovating this novel model system is that the SARM 
KO (knockout) mice harbor a heterogenous T cell population 
expressing a wide repertoire of TCRs, hence the number of virus-
specific CD8 T cells will be too low to study the recruitment of naïve T 
cells in response to an infection. Endogenous CD8 T cells specific for 
immunodominant epitopes of influenza virus are usually below 
detection limit in tissues before clonal expansion and during clonal 
contraction. Hence, it will be difficult to follow the T cell immune 




response in SARM KO mice. The expression of diverse TCR by the 
responding polyclonal CD8 T cells would complicate direct 
comparison of their persistence at different time points during T cell 
immune response in the SARM KO mice. In view of these considerable 
setbacks with the use of SARM KO mice, we strategically planned and 
developed a novel in vivo “adoptive transfer” mouse model system to 
study the effect of SARM knockdown during an experimental 
influenza infection. Using the “adoptive transfer” mouse, we can 
monitor a cohort of CD8 T cells specific for the same epitope to 
accurately follow T cell immune response. During respiratory 
influenza infection, the major lymphocyte population that contributes 
to the cell-mediated inflammatory immune response is CD8 T cells 
(Allan et al., 1990). Hence, we specifically employed influenza infection 
model system to follow the immune response of CD8 T cells. 
 
The model system includes two major components:  
1. CD8 T cells expressing a transgenic TCR, called OTI and 




2. a recombinant influenza virus that expresses the SIINFEKL 
epitope recognized by the OTI TCR – WSN SIINFEKL (Topham et 
al., 2001).  
        
In a typical experiment the naïve OTI CD8 T cells from OTI TCR 
transgenic mice on C57BL/6 background are activated and transduced 
with SARM-specific shRNA and GFP expressing retrovirus. The 
retroviral transduced memory T cells are adoptively transferred into 
congenic C57BL/6 – Thy1.1 mice to study the effect of SARM 
knockdown during T cell immune response to experimental influenza 
infection (Figure 2.5). Detailed description of the methodology is 
included in the materials and methods section (see section 3.14). 
 
 
Figure 2.5: Schematic representation of the development of a suitable 
mouse model to study the effect of SARM-knockdown during influenza 
infection. 




2.1.6. NK/T cell lymphoma patient’s biopsy samples  
NK/T cell lymphoma is prevalent in Asia. Hence, we used NK/T cell 
lymphoma biopsy samples to study the expression of SARM in 
diseased state. Patient tissues diagnosized of NK/T cell lymphoma 
were identified from archives of Department of Pathology, National 
University Hospital (NUH), from 1990 to 2009 (Ng et al., 2011). Formal 
fixed paraffin embedded (FFPE) tissues of below stated 6 cases of NK/T 



























Table 2.1: List of NK/T cell lymphoma diagnosed patient’s biopsy  
                    tissues that were used for this study.  
                                                        










CD4 CD8 CD56 
NKTL1 
16 
NKTL 48/M Chinese Nasal 1998 - - + 
NKTL 
17 
NKTL 69/M Chinese Lymph 
node 
1992 - - + 
NKTL 
22 
NKTL 46/M Chinese Skin 2000 - - - 
NKTL 
23 
NKTL 51/M Chinese Skin 2008 + - + 
NKTL 
25 
NKTL 17/M Chinese jejunum 2006 - + + 
NKTL 
27 





3. Materials and Methods                                                                                                   
3.1. Materials  
Full length SARM (SARM FL) expression construct was purchased 
from Invivogen Inc., USA.  Truncated expression constructs: ARM-
SAM-TIR (AST), SAM-TIR (ST), TIR and SAM were obtained from 
Prof. Aihao Ding, Cornell University. The constructs expressing N 
ARM1, N ARM2, ARM1 ARM2, SARM ∆TIR, SARM 234, N124 and S27 
were subcloned from pUNO SARM cDNA (Invivogen Inc., USA) into 
pEGFPN3 vector (see Table 3.2). S27 peptide corresponding to the first 
27 amino acids at the N-terminus of SARM (MVLTLLLSAY 
KLCRFFAMSG PRPGAER), TMR-labeled S27 and negative control 
negS1 (GFELEGMAEISCLPNGQWSNFPPKCIRECAMVSS) (Leptihn et 
al., 2009) were synthesized and purified to >95% purity by Genemed 
Synthesis Inc. (SF, USA). Bcl-xL expression plasmid in pCMV construct 
was purchased from Clontech. SARM specific and non-targeting 
control shRNA sequences (see Table 3.2) were cloned in pMKO.1 GFP 
plasmid. The non-targeting control and SARM specific siRNAs were 
purchased from Invitrogen, USA. SIINFEKL peptide was synthesized 
and purified to >95% purity by Genemed Synthesis Inc. (SF, USA). 





inhibitor MG132 were from Calbiochem. Mitochondrial membrane 
potential-sensitive dye (tetramethylrhodamine ester perchlorate, 
TMRE-87917), mitochondrial charge uncoupler (carbonyl cyanide 3-
chlorophenylhydrazone, CCCP), Propidium Iodide, Hoechst 33342 and 
Complete Freund’s Adjuvant were from Sigma. ROS indicator 
(CMH2DCFDA), LipofectamineTM LTX, Mitotracker, far-red labeled 
transferrin, CFSE and recombinant mouse IL-2 were from Invitrogen, 
USA. Recombinant mouse IL-7 was from R & D systems. Recombinant 
human IL-2 was from Miltenyi Biotec. Fluorogenic apoptosis assay 
substrate, caspalux and phiphilux, were from OncoImmunin Inc., USA. 
Anti-CD3 and Annexin V- FITC were from E bioscience. The antibody 
against the N terminal of SARM was obtained from Prof. Yi-Ping 
Hseuh of Institute of Molecular Biology, Taiwan. Rabbit polyclonal 
anti-SARM, mouse monoclonal anti-GAPDH and mouse monoclonal 
anti-PDH E1 were from Santa Cruz. Rabbit polyclonal anti-actin was 
from Sigma. Rabbit polyclonal anti-VDAC and rabbit monoclonal anti-
pERK were from Cell signalling. Rabbit polyclonal anti-GFP was from 
Clontech. Rabbit polyclonal anti-turboGFP was from Evrogen. Mouse 
monoclonal anti-Cytochrome c was from BD Pharmingen. Dead cell 





APC, anti-CD4-PE, anti-CD8-PE, anti-CD3-APC, anti-CD95-PE, anti-
CD95L-PE, anti-Thy1.2- PE Cy7, anti-CD25 APC, anti-CCR7 APC, anti-
CD62L APC were from Bio Legend. Gold conjugated anti-rabbit and 
anti-mouse secondary antibodies were from Ted Pella Inc (USA). 
Fluorochrome conjugated anti-rabbit and anti-mouse secondary 
antibodies were from Invitrogen. Other common chemicals were of 
molecular biology grade, from Sigma-Aldrich or Merck. 
 
3.2. Mice 
Transgenic T cell receptor OTI+ RAG-/- mice, were from Taconic Farms, 
Inc. These mice express transgenic TCR on CD8 T cells, recognizing 
SIINFEKL peptide presented by the MHC class I molecule H2-Kb. 
B6.PL-Thy1a/CyJ mice (The Jackson Laboratory) expressing the 
congenic Thy1.1 marker, were used as recipients at 8-12 weeks of age. 
The animals were bred and handled in SPF environment under 
Institutional Animal Care and Use Committee guidelines (NUS 








3.3. Cell culture and Transfection  
3.3.1. HEK 293T, HEK 293 Bcl-xL, NIH 3T3, NK-YS, Raji B, Neuro-2a,    
          WT MEF and BAX-/- BAK-/- MEF cell lines      
HEK 293T, HEK 293 Bcl-xL, NIH 3T3, Wild type mouse embryonic 
fibroblast (WT MEF) and BAX-/- BAK-/- MEF cell lines were maintained 
in DMEM containing 10% (v/v) fetal bovine serum, 100 Units/ml 
penicillin and 100 µg/ml streptomycin. Both MEF cell lines were kind 
gifts from Dr. Victor Yu, National University of Singapore. HEK 293 
Bcl-xL cell line was purchased from Invivogen. HEK 293 Bcl-xL cell 
line was continuously selected in the media containing 10 g/ml 
Blasticidin. NK-YS (NK/T lymphoma cell line) was maintained in 
RPMI containing 10% (v/v) fetal bovine serum, 100 Units/ml 
penicillin, 100 g/ml streptomycin and 100 Units/ml recombinant 
human IL-2. Raji B (Burkitt’s lymphoma cell line) was maintained in 
RPMI containing 10% (v/v) fetal bovine serum, 100 Units/ml penicillin 
and 100 g/ml streptomycin. Neuro-2a (Neuroblastoma cell line) was 
maintained in MEM containing 10% (v/v) fetal bovine serum, 100 
Units/ml penicillin and 100 g/ml streptomycin. 
 
Either HEK 293T or HEK 293 Bcl-xL cells were seeded in 12-well plates 





overnight before transfection. Each transfection mixture containing 800 
ng of plasmid in 200 l of incomplete medium and 2 l of 
LipofectamineTM LTX (Invitrogen) was incubated at room temperature 
for 30 min. Transfection mixture was then added to the cells. 6 x 104 
NIH 3T3 cells/well seeded in 12-well plates were transfected as 
described for HEK 293T cells. 8 x 104 MEF cells/well seeded in 12 well 
plates were transfected as described for HEK 293T cells. For gene 
delivery into NK-YS, Neuro-2a and Raji B cells, 1-2106 of each cell line 
were resuspended in 100 l nucleofector solution (Amaxa GmbH, 
Köln, Germany) and electroporated using A-024, T-024 and M-013 
nucleofector programs respectively, in the nucleofector device. 
Following nucleofection, the cells were immediately transferred into 
pre-warmed RPMI 1640 medium in 12-well plates and incubated at 
37oC with 5% CO2. 
  
3.3.2. Primary cytotoxic T cells 
Primary cytotoxic T cells were obtained from lymph nodes isolated 
from OTI+ RAG-/- mice. The mouse was euthanized using carbon 
dioxide chamber. The mouse was then dissected to isolate various 





glass slides and filtered through 80 m nylon filter. To check the purity 
of the isolated cytotoxic T cells, the cells were stained with anti-CD8 PE 
and anti-CD3 APC (1:100 dilution) for 8 min. Following incubation, the 
cells were washed in FACS buffer (PBS with 0.5% BSA and 0.1% 
sodium azide) and analyzed by flow cytometry. 
 
PBS containing anti-CD3 (5 g/ml) was added to the required number 
of wells in 24 well plate and incubated in cell culture incubator for 2 h. 
Following anti-CD3 coating the PBS was replaced with the freshly 
isolated cytotoxic T cells in RPMI containing 10% (v/v) fetal bovine 
serum, 50 M 2-mercaptoethanol, 100 Units/ml penicillin, 100 g/ml 
streptomycin and 100 Units/ml IL-2. The cells were activated for 24 h. 
 
For gene delivery into primary T cells, 1-2106 activated cells were 
resuspended in 100 l nucleofector solution (Amaxa GmbH, Köln, 
Germany) and electroporated using program X-100 in the Nucleofector 
device. Following nucleofection, the cells were immediately transferred 
into pre-warmed RPMI 1640 medium in 12-well plates and incubated 






3.4. Functional characterization of mitochondrial association of  
       SARM  
3.4.1. Tyrosine fluorescence scanning spectrometry 
250 M of S27 peptide or negS1 control peptide, was mixed with 
increasing concentrations of a suspension of phospholipids, 
POPC:POPG (2:1) in a 96-well plate. Samples were excited at either 274 
nm (λex for peptide containing Tyrosine) or 280 nm (λex for peptide 
containing Tryptophan), and the fluorescence emission spectrum was 
either scanned from 300-500 nm or read at Tyrosine λmax (303 nm), 
respectively, using BioTek fluorescence plate reader. 
 
3.4.2. Dot blot assay  
Equal amounts of POPE and POPG in 5 l aliquots were spotted onto a 
PVDF membrane, air-dried and incubated with 50 M TMR-labeled 
S27 peptide at room temperature in the dark for 2 h. After washing 3 
times with 20 mM phosphate buffer (pH 7.0), the fluorescence was 









3.4.3. Mitochondrial fractionation and binding assay 
Mitochondria and cytosol fractions were isolated from HEK 293T cells 
by differential centrifugation using mitochondria isolation kit by 
following the manufacturer’s protocol (Pierce Biotechnology) (700g 
for 10 min to get rid of cell debris, followed by 12,000g for 15 min to 
separate mitochondria from cytosol). Mitochondria isolated from 106 
cells were resuspended in 100 l of cold PEB buffer (PBS pH 7.2, 2 mM 
EDTA and 0.5% BSA) and indicated amounts of TMR-labeled peptide 
were added. After 30 min incubation in the dark at 4C, mitochondria 
were washed thrice with cold PEB buffer and then analyzed by LSRII 
flow cytometer. Flow Jo software was used for data analysis.  
 
Mitochondrial and cytosolic fractions were isolated from primary T 
cells, untransfected, N124-, SARM FL- and S27- transfected HEK 293T 
cells. Lysates were resolved in 12 % SDS-PAGE gel and transferred on 
to PVDF membrane. The membrane was blocked with 5 % skimmed 
milk in PBST (PBS containing 0.05% v/v of Tween 20) for 1 h and 
incubated overnight at 4C with the primary antibody against SARM 
(1:200) or GFP (1:1000) in the blocking buffer. The membrane was 





antibody coupled to HRP in blocking buffer. Finally the membrane 
was washed again three times and the bound HRP was detected using 
Supersignal® West Pico (Pierce) chemiluminescent substrate according 
to the manufacturer’s protocol. To ensure equal loading, the same 
membrane was stripped using Thermo Scientific restore Western blot 
stripping buffer for 30 min at 37C. The same membrane was reprobed 
with anti-VDAC (1:500), mitochondrial marker and anti-GAPDH 
(1:5000), cytoplasmic marker. 
 
3.4.4. Immunostaining and fluorescence imaging 
1106 activated primary T cells were nucleofected with different 
truncated constructs of SARM. Cells were collected 6 h post-
nucleofection. 2 x 105 HEK 293T cells were seeded overnight in a 12-
well plate before transfection for 12 h with different truncated 
constructs of SARM. Following transfection or nucleofection, cells were 
incubated with 10 nM mitotracker or 10 g/ml labeled transferrin for 
20 or 35 min, respectively. The cells were washed and fixed in 4% 
formaldehyde for 15 min at room temperature, washed thrice with 
PBST, and mounted on the glass slide with mounting medium 





cells were fixed and permeabilized. The cells were then stained with 
anti-cytochrome c (1:200), followed by alexa fluor 546 conjugated 
donkey anti-mouse (1:1000).  The cells were mounted on the glass slide 
with mounting medium containing DAPI. The images were obtained 
using LSM META 510 confocal laser scanning microscope under 100 X 
DIC objective and numerical aperture of 0.55 (Carl Zeiss). Images were 
acquired using Carl Zeiss LSM 5 software, version 4.0 SP2.  
 
For mitochondria clustering assay microscopic fields were randomly 
chosen at 5 time-points after transfection of SARM 234-GFP or GFP 
vector in HEK 293T cells. The number of cells with clustered 
mitochondria was counted out of 150 GFP-positive cells, and the 
percentage was calculated.  
 
3.4.5. Site-directed mutagenesis of S27 
Plasmids K11A, R14A, R21A, R27A and R14A SARM FL were made by 
site directed mutagenesis kit according to manufacturer’s instructions 
(QuikChange XL Site-Directed Mutagenesis Kit). The oligonucleotides 
were designed using web-based QuikChange Primer design program 





was carried out using the SARM FL pEGFPN3 or S27 pEGFPN3 vector. 
Mutant strands were synthesized using Pfu Turbo DNA polymerase. 
The methylated, non-mutated parental DNA template was then 
digested with Dpn I. The mutated plasmid was then transformed into 
competent cells. The site-directed mutagenesis was confirmed by 
sequencing the transformed plasmids.  
 
3.4.6. Immunogold double labeling    
HEK 293T cells were transfected with S27-EGFP, SARM FL-EGFP and 
at 24 h post-transfection, the cells were fixed with 4% 
paraformaldehyde and 1% glutaraldehyde at 4C for 3 h. The cells 
were washed twice in PBS and left at 4C overnight. Next day, the cells 
were washed with distilled water and dehydrated in ascending 
ethanolic series (25%, 50%, 75%, 95% and 100%). Cells were then 
gradually infiltrated with LR white resin. The cells were passed 
through 4 changes of absolute LR white resin to ensure complete 
infiltration. The infiltrated cells were transferred to BEEM capsule 
inserted in gelatin capsule. The cells were then polymerized at 50C for 






Using ultramicrotome, gold sections containing HEK 293T cells were 
cut from the embedded LR white resin. The gold sections were 
transferred on to the nickel grid for immunogold labeling. The nickel 
grids were washed to remove the residual aldehyde. The grids were 
stained with rabbit anti-EGFP (1:100, Abcam) and mouse anti-PDH 
E1 (1:20, Santa Cruz) and followed by incubation with gold 
conjugated anti-mouse and anti-rabbit secondary antibodies (Ted 
Pella). The grids were stained with osmium tetroxide, uranyl acetate 
and lead citrate. The samples were then observed using JEM1010 TEM. 
 
3.5. Bioinformatics analysis   
3.5.1. Phylogenetic analysis of SARM  
The sequences of various SARM homologues were obtained from 
PubMed database. Table 3.1 summarizes the list of SARM homologues 
that were employed for the phylogenetic analysis. Multiple sequence 
alignment was performed using software package ClustalX. Rooted 
phylograms were prepared with the neighbor-joining algorithm and 
plotted by using Njplot. The branch lengths of the tree are proportional 





shown (0.05-nt changes per site). Branch labels record the stability of 
the branches >10000 bootstrap replicates.  
 




Code Name Protein description Organism Pubmed 
Accession No. 
1 AaSARMa sarm1 (Aedes aegypti) Aedes aegypti XP_001650024.1 
2 AaSARMb sarm1 [(Aedes 
aegypti) 
Aedes aegypti XP_001650025.1 


















6 AmSARM Ect4 sterile alpha and 
TIR motif-containing 
protein 1 
Apis mellifera XP_394430.3 
7 BmSARM sterile alpha and TIR 
motif containing 
protein 1 isoform a, 
putative 
Brugia malayi XP_001900379.1 















































13 CfSARM SARM1 sterile alpha 




















17 DmSARMe Ect4, isoform E Drosophila 
melanogaster 
NP_729327.1 

















22 EcSARM sterile alpha and TIR 




23 GgSARM SARM1 sterile alpha 
and TIR motif 
containing 1 
Gallus gallus XP_415814.2 
24 HsSARM SARM1 sterile alpha 
and TIR motif 
containing 1 











26 MdSARM similar to sterile alpha 
and TIR motif 




27 MmSARM1 sterile alpha and TIR 
motif-containing 
protein 1 isoform 1 
Mus musculus NP_001161993.
1 
28 MmSARM2 sterile alpha and TIR 
motif-containing 
protein 1 isoform 2 
Mus musculus NP_766383.2 
29 NvSARM similar to sarm1 Nasonia 
vitripennis 
XP_001601657.1 










3.5.2. Polybasic domain analysis  
Polybasic domain of TRAM, a TLR adaptor was reported to be 
important for membrane association (Kagan et al., 2008), hence we 
tested if SARM possess a similar polybasic domain. The isoelectric 
points of sequential 30-amino acid segments of various SARM 
homologues were calculated using online ExPASy server 
(http://web.expasy.org/compute_pi/). The consecutive pIs of various 
SARM homologues were plotted in the line graph to identify the 






A protein domain search was conducted by various databases like 
ExPASy (SIB), CDD (NCBI) and Pfam (SI), to determine the exact 
location of all the domains in SARM sequence. SARM function was 
predicted using SVMprot analysis (http://jing.cz3.nus.edu.sg/ cgi-
bin/ svmprot. cgi). To characterize the mitochondria targeting signal 
sequence of SARM, following in silico analysis were made. Hydropathy 
plot was drawn for the first 30 amino acids of SARM based on the 
hydrophobicity score obtained from ProtScale online server 
(http://web.expasy.org/protscale) using Kyte and Doolittle amino 
acid scale value. The secondary structure of SARM was predicted 
using PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/). Helical wheel 
projection of the N-terminus of SARM was plotted using software 
(http://cti.itc.virginia.edu/~cmg/Demo/wheel/wheelApp.html). 
 
3.6. Apoptosis assays 
3.6.1. 7-AAD exclusion dye staining assay 
7-AAD is the cell membrane impermeable DNA binding dye. As cell 
membrane of apoptotic cells are compromised, 7-AAD stains apoptotic 
cells but not healthy cells.  HEK 293T or cytotoxic T cell or Raji B cells 





constructs of SARM. At indicated time following transfection, the cells, 
were resuspended in FACS buffer containing 5 l of 7-AAD solution as 
suggested by E bioscience. The cells were then incubated on ice for 5 
min and then analyzed by flow cytometry.  
 
3.6.2. Nuclear condensation by DAPI staining assay 
Nuclear condensation is a hallmark apoptotic phenotype. Nuclear 
condensation of SARM ST-transfected cells was visualized by DAPI 
staining. Cells grown on the cover slip were transfected with SARM 
ST/ GFP. 24 h post-transfection the cells were mounted on the glass 
slide with DAPI containing mounting media. SARM ST-GFP positive 
cells in 20 random microscopic fields were enumerated and the 
percentage of cells with condensed nuclei was calculated against GFP-
transfected controls. 
 
3.6.3. TUNEL assay for nuclear fragmentation 
TUNEL assay detects DNA fragmentation by labeling the nicked ends 
of DNA using terminal deoxynucloetidyl transferase enzyme. 
Transfected HEK 293T cells were fixed with 4% formaldehyde and 





on ice. After washing with PBS, 50 l of TUNEL reaction mixture 
(Roche) was added. Cells were incubated in a humidified dark 
chamber at 37C for 1 h and washed thrice. Cells were analyzed by 
flow cytometry (λex 540 nm /λem 580 nm). Cells treated with DNase I 
for 10 min at room temperature served as positive control. 
 
3.6.4 Hoechst and Propidium iodide double staining assay 
To test if nuclear condensation occurs before the cell membrane is 
compromised, transfected cells were resuspended in ice-cold PBS 
containing 5 g/ml Hoechst 33342 (cell permeable DNA binding dye) 
and 1 g/ml of Propidium iodide (cell impermeable DNA binding 
dye). The cells were then incubated on ice for 30 min. Stained cells 
were analyzed by flow cytometry, using UV488 nm dual excitation and 
measuring the fluorescence emission at ~460 nm and > 575nm. 
 
3.6.5. Analysis of MPTP formation  
To study the MPTP formation, following transfection or nucleofection, 
at indicated time intervals, 10 nM of TMRE was added to cell culture 
medium. Only active mitochondria sequester TMRE while formation of 





potential (m) can be measured based on TMRE fluorescence. After 
20 min incubation at 37C, cells were washed and resuspended in 
FACS buffer containing 0.5% BSA and 0.1 % sodium azide in PBS. Cells 
treated with 50 M CCCP for 1 h was employed as a positive control. 
FACS analysis was performed at λex 540 nm /λem 595 nm. 
 
3.6.6. Caspase activity assay 
After transfection/nucleofection, cells were washed and centrifuged in 
FACS buffer. Cell pellets were resuspended in 30 l of caspase-3 
substrate (phiphilux), or caspase-9 substrate (caspalux) or caspase-8 
substrate (caspalux) and incubated for 40 min at 37C. After washing in 
FACS buffer, the cells were analyzed at λex 552 /λem 580 nm. 
 
3.6.7. Intracellular ROS assay 
To measure the levels of intracellular ROS, transfected HEK 293T cells, 
10 M freshly prepared CM-H2DCFDA was added and incubated for 
30 min at 37oC. Cells were washed, resuspended in FACS buffer and 
fluorescence (λex 515 nm/ λem 488 nm) was measured by flow 






3.6.8. GFP cotransfection assay and trypan blue dye exclusion assay 
To exclude the possibility that GFP fusion tag might affect the function 
of SARM, HEK 293T cells were cotransfected with pCDNA/ SARM 
ST/ SARM TIR and GFP in the ratio of 5:1. At 24 h post-transfection, 
GFP positive cells were analyzed by flow cytometry. Percentage of 
GFP-positive cells and mean GFP fluorescence intensity was measured 
by flow cytometry at indicated time points post-transfection for each of 
the SARM constructs. The cells were also stained with trypan blue and 
dead cells were counted using improved Neubauer hemocytometer 
chamber. HEK 293T cells were transfected with varying ratios of GFP: 
SARM (1:1, 1:2, 1:3, 1:4, 1:5) and at 24 h post-transfection, the mean 
fluorescence intensity was measured by flow cytometry. The total 
amounts of the recombinant plasmid DNA were balanced with 
pCDNA vector. 
 
3.7. Co-immunoprecipitation assay  
To study potential interaction of SARM with Bcl-2 family members, co-
immunoprecipitation was carried out. Primary OTI CD8 T cells were 
activated by plate-bound anti-CD3 for up to 4 days. T cell lysates were 





2 or anti-Bcl-xL. Cells were lysed in non-denaturing lysis buffer (Tris-
EDTA pH 7.4, 1% Triton-X100, NaCl, Sodium azide). Total lysates were 
precleared using Protein-G beads. Precleared lysates were incubated 
overnight with anti-Bcl2 or anti-Bcl-xL. The antibody bound proteins 
were captured using Protein-G beads. The bound proteins were eluted 
using Laemmli loading buffer. Both the eluate and lysate fractions 
were electrophoresed and probed for Bcl-2 (1:1000)/ Bcl-xL (1:1000) 
and SARM. The membranes were stripped and reprobed for the 
presence of BAX (1:1000), the reported interaction partner of both Bcl-2 
and Bcl-xL.  
 
3.8. In vitro activation of primary T cells  
Primary CD8 T cells obtained from OTI+ RAG-/- mouse was activated 
using plate bound anti-CD3 as described in section 3.3.2. To study the 
biological importance of SARM during T cell activation, the following 
analyses were made.  
 
3.8.1. CD69, CD44, CD25, FAS and FASL expression on T cell  
          activation  
To confirm the activation of primary T cells by anti-CD3, the cells were 





anti-CD69 and anti-CD25. To test the expression of death (FAS) and 
death receptor (FASL), the cells were stained with fluorochrome 
conjugated anti-CD95 and anti-CD95L. To the activated T cells 
resuspended in FACS buffer (PBS with 0.5% BSA and 0.1% sodium 
azide), specific fluorochrome conjugated antibodies were added at the 
dilution of 1:100. The cells were incubated on ice for 10 min. Following 
incubation, the cells were washed with FACS buffer. Cells were 
pelleted at 1000 g for 5 min at 4C and then resuspended in FACS 
buffer and analyzed using either LSR II or ARIA (BD Bioscience) 
depending on the λex /λem of the conjugated fluorochrome. The data 
files were analyzed using Flow Jo software. 
 
3.8.2. CFSE labeling of T cells  
Cell proliferation of activated T cells was assessed by CFSE labeling. 
Primary T cells (50 x 106 cells per ml) were mixed with 10 M CFSE in 
the ratio 1:1 by vortexing. The cells were then incubated in the dark for 
exactly 5 min. Longer incubation might hamper the growth and 
proliferation of cells. The reaction was neutralized by adding PBS 





remove the residual CFSE. The cells were then analyzed by flow 
cytometry (λex 515 nm/ λem 488 nm). 
 
3.8.3. Protein expression profiling of SARM on T cell activation  
Activated primary CD8 T cells were lysed on the indicated days post-
activation and total cell lysate was prepared using RIPA buffer (Cell 
Signaling Inc). Lysates were resolved in 12% SDS-PAGE gel and 
transferred on to PVDF membrane. The membrane was probed with 
anti SARM (1:200) followed by corresponding secondary antibody. To 
ensure equal loading, the same membrane was stripped and reprobed 
with anti-actin (1:1000).  
 
3.9. Transient knockdown of SARM  
Efficiency of SARM knockdown by SARM-specific siRNA was 
validated in NIH 3T3 cells. NIH 3T3 cells were cotransfected with 
SARM specific or control siRNA and GFP. At 36 h post-transfection, 
the NIH 3T3 cells were sorted based on the GFP expression. The cells 
were either lysed with either RNA lysis buffer for RT PCR or RIPA 
buffer for Western blot analysis. RNA was isolated with RNA micro kit 





digestion was performed using RNase free DNase. RNA was reverse-
transcribed with superscript III reverse transcriptase (Invitrogen) using 
oligo-dT primer according to the manufacturer’s instructions. The 
cDNA obtained was used for real time PCR with SYBR Green I Master 
mix (Roche) using the LightCycler® 480 II cycler detection system to 
determine the relative amount of SARM mRNA. Tubulin was used as 
the internal control. Western blot analysis was performed using anti-
SARM and loading control anti-actin. 
 
3.10. Stable knockdown of SARM by retroviral transduction  
SARM-specific shRNA was cloned into retroviral vector pMKO.1 GFP 
(see table 3.2). Around 1 x 106 HEK 293T cells were plated on 6 well 
plate. pCL-ECO packaging plasmid and pMKO.1 GFP plasmids 
containing SARM-specific shRNA or non-targeting control shRNA 
were cotransfected into HEK 293T cells using Lipofectamine LTX. 
Retrovirus-containing supernatant was collected two days post-
transfection. The retrovirus supernatant was directly added to the 
activated OTI CD8 T cells in 24-well plates. The cells were spinoculated 





the T cells were analyzed for expression of GFP to determine the 
transduction efficiency. 
 
3.11. Neglect-induced cell death assay  
2x106 activated CD8 T cells were nucleofected with 2 g of pEGFPN3 
plasmid and increasing amounts of SARM specific/ control siRNA 
(Invitrogen). 24 h post-nucleofection, cells were either cultured in the 
absence of IL-2 (100 Units/ml) to induce neglect-induced cell death. 24 
h later dead cells were enumerated by counting the percentage of GFP-
positive cells that were 7-AAD-positive by flow cytometry. 
 
3.12. Activation-induced cell death assay 
Primary cytotoxic T cells stably expressing SARM specific shRNA/ 
control shRNA were restimulated in the plate bound anti-CD3 to 
induce activation-induced cell death. 24 h later dead cells were 
enumerated by counting the percentage of GFP-positive cells that were 
7-AAD-positive by flow cytometry. GFP positive SARM shRNA/ non-
targeting control shRNA transduced T cells were tracked for up to 9 






3.13. Sorting of early and late apoptotic cells 
Activated primary cytotoxic T cells were pelleted and washed once in 
the binding buffer (supplied in the kit). 5 x 106 cells were resuspended 
in 600 l of binding buffer and 30 l of FITC conjugated Annexin V. 
The cells were incubated for 30 min at room temperature. The cells 
were then washed in the binding buffer and resuspended in 500 l of 
binding buffer containing 7-AAD. The cells were then sorted into three 
populations - double negative cells, Annexin single positive cells and 
Annexin and 7-AAD double positive cells, in three separate tubes by 
FACS Aria cell sorter. The sorted cells were then immunoblotted. 
 
3.14. Adoptive transfer mouse model system 
We designed a suitable adoptive transfer mouse model system to study 
the effect of SARM knockdown during T cell immune response to 
influenza infection.   
 
3.14.1. In vitro memory T cell development  
Naïve OTI CD8 T cells obtained from the spleen and lymph nodes of 
OTI+ RAG-/-mice were stimulated using 1 g/ml SIINFEKL peptide. 





CD69, CD44 and CD25 as described in section 3.8.1. The activated cells 
were then transduced with either SARM specific shRNA or non-
targeting control shRNA containing retrovirus supernatant in 24-well 
plates. Two days post-retroviral transduction, the T cells were cultured 
in the medium containing 5 ng/ml rIL-7. The cells were cultured the 
cells for 3 days. Then, the cells were washed and the medium was 
refreshed with 10 ng/ml rIL-7 and the cells were cultured for more 
than 2 weeks to develop in vitro memory T cells. The cells were 
analyzed for the expression of memory T cell markers – CCR7 and 
CD62L as described in section 3.8.1.   
 
3.14.2. Production and titration of WSN-SIINFEKL influenza virus  
WSN-SIINFEKL Influenza virus was produced using MDCK (Madin-
Darby Canine Kidney) cell line. MDCK cell line is maintained in MEM 
containing 10% (v/v) fetal bovine serum, 100 Units/ml penicillin and 
100 g/ml streptomycin.  
 
For virus production, MDCK cells in the confluent 25 cm2 flask were 
washed twice with PBS and once with incomplete MEM containing 2 





PFU) was diluted in 500 µl of MEM containing TPCK-treated trypsin. 
The cells were incubated for 1 h with gentle shaking at 15 min 
intervals. After incubation, about 5 ml of incomplete MEM containing 
TPCK-treated trypsin and 0.2% of BSA was added to the flask. The 
cells were monitored for cytopathic effect every day. On day 3 post-
infection, the virus-containing supernatant was collected and 
centrifuged at 1000xg for 10 min at room temperature to remove any 
residual cells. The virus-containing supernatant was aliquoted and 
stored at -80C. 
 
For titration of virus, 0.1 x 106 MDCK cells were seeded in 24 well 
plate. Viruses were serially diluted in incomplete MEM containing 
trypsin (up to 5 fold dilutions). 100 l of MEM containing viruses were 
added to each of the 24 well plate. Infection was carried out as 
described above. After 1 h the wells were layered with 1 ml of MEM 
containing trypsin, 0.2% BSA and 1.2% avicel (FMC BioPolymer CL-
611F or RC-591F). The cells were incubated for 2 days. The 1 ml overlay 
medium was aspirated and cells were incubated with formalin for 30 
min. The plate was then washed with water. Then the cells were 





washed and allowed to air dry. The plaques were then counted to 
calculate the viral titer. 
  
3.14.3. Adoptive transfer and influenza infection  
5 x 105 retrovirally transduced OTI CD8 memory T cells were injected 
intravenously into congenic B6-Thy1.1 recipient mice. The adoptively 
transferred T cells (OTI CD8) can be distinguished from the T cells of 
the recipient mice based on the T cell surface antigen - Thy. The mice 
were then infected with a sublethal dose of WSN SIINFEKL virus (75 
PFU) by intratracheal instillation under anesthesia. To analyze the OTI 
T cell response, the lung draining mediastinal lymph nodes, peripheral 
lymph nodes and spleen were crushed with the frosted glass slides and 
filtered through 80 m nylon filter. The cells were then stained with 
anti-CD8 PE and anti-Thy1.2 PE-Cy7, and analyzed by flow cytometry 
to follow the T cell immune response (IACUC protocol number 
084/08).  
 
3.15. In vivo activation of T cells by footpad injection  
SIINFEKL peptide was thoroughly mixed with Complete Freund’s 





hind footpad with 30 l of Complete Freund’s Adjuvant emulsion 
containing 5 g of SIINFEKL. The corresponding draining popliteal 
and inguinal lymph nodes were obtained and checked for T cell 
activation marker, CD69, as described in section 3.8.1. The popliteal 
and inguinal lymph node cells were pooled and stained with trypan 
blue dye, to count the total number of live cells. The total number of 
live cells was enumerated using a neubauer hemocytometer chamber. 
The RNA was extracted from these lymph node cells and SARM 
expression profile was analyzed as described in section 3.9. The 
experiment was terminated at a humane endpoint based on IACUC 
guidelines (IACUC protocol number 018/09). 
 
3.16. Realtime PCR of SARM expression in NK /T cell lymphoma  
          FFPE tissue  
This work was performed in collaboration with Dr. Chng Wee Joo and 
Dr. Ng Siok Bian of the National University Hospital. Total RNA from 
NK/TL FFPE (formalin-fixed paraffin embedded) tissues was isolated 
using a high pure RNA Paraffin Kit following the manufacturer’s 
instructions. Normal NK cells were purified from buffy coat obtained 
from healthy donors by ficoll density gradient centrifugation and NK 





stimulated by culturing in the presence of human recombinant IL-2 
(Miltenyi Biotec). To correlate the expression of SARM in other NK/TL 
derived cell lines, RNA was isolated from NK/TL cell lines - NK-92, 
KHYG-1, HANK-1, SNK-6, SNT-8 and NK-YS. RNA was extracted 
using RNeasy mini kit (Qiagen). RNA was reverse transcribed using 
random hexamer primers and superscript reverse transcriptase 
(Invitrogen). Real time PCR was performed as described in section 3.9. 
 
3.17. Statistical analysis 
Data represent means  SD of three independent experiments. 
Statistical significance was calculated based on two-tailed Student’s t 
test.    
 
Table 3.2: Oligonucleotides used in this study.  
S27 
(pEGFPN3) 






















Lys11Ala Sense 5’-GCTTCTCTCCGCCTACGCGCTGTGTCGCTTCTTC-3’ 
Antisense 5’-GAAGAAGCGACACAGCGCGTAGGCGGAGAGAAGC-3’ 
Arg14Ala Sense 5’-CGCCTACAAGCTGTGTGCCTTCTTCGCCATGTCG-3’ 
Antisense 5’-CGACATGGCGAAGAAGGCACACAGCTTGTAGGCG-3’ 
Arg22Ala Sense 5’-GCCATGTCGGGCCCAGCGCCGGGCG-3’ 
Antisense 5’-CGCCCGGCGCTGGGCCCGACATGGC-3’ 




































































4. Results                                                                                                   
4.1. Primary murine cytotoxic T cells express SARM 724 isoform 
Domain prediction algorithms indicated that SARM possesses a unique 
combination of two N-terminal ARM domains (residues 124 – 234), 
two SAM domains (residues 409-702) and a C-terminal 
Toll/Interleukin-1 receptor (TIR) domain (residue 561 to 702). The 
human and mouse SARM share 93% homology (ClustalW, Multiple 
sequence analysis). Two mouse isoforms of 724 and 764 amino acids 
are reported (NCBI accession number NP_766383 and 
NP_001161993.1). The shorter isoform is the splice variant of the longer 
isoform. The additional 40 amino acids in SARM 764 are located 
between the SAM and TIR domains (Figure 4.1). 
 
Figure 4.1: Domain architecture of human and mouse SARM. The location 
of two ARM, two SAM and one TIR domains are indicated. The difference in 
the two splice variant isoforms of mouse SARM is underlined, indicating the 
40 amino acid (AA) insertion in 764 isoform. The human and mouse SARM 






Firstly, reverse transcriptase PCR of primary mouse T cell mRNA was 
carried out to check if it expresses SARM 724 or SARM 764. Primers 
were designed between the SAM and TIR domains of SARM. RT PCR 
amplified only the 367 bp product corresponding to SARM 724 and not 
the 487 bp corresponding to SARM 764 indicating that mouse T cells 
do not express the longer isoform but only the SARM 724 (Figure 4.2). 
Hence we specifically focused on SARM 724 isoform.     
 
Figure 4.2: T cells express SARM 724 isoform. PCR reaction was carried out 
using cDNA prepared from RNA isolated from primary mouse CD8 T cells. 
Blue and red arrows indicate forward and reverse primers, respectively. 
Lanes L: 100 bp DNA ladder, 1 and 2 are amplification with SARM-specific 
primers without/with cDNA, respectively, and 3 and 4 are amplification with 






PubMed earlier reported SARM to be a 690-amino acid protein 
(NM_015077). Mink, Carty, Peng and Liberati et al employed and 
described SARM 690 in their studies (Carty et al., 2006; Liberati et al., 
2004; Mink et al., 2001; Peng et al., 2010). However, recently NCBI 
retracted the 690-amino acid form and now publishes the 724-amino 
acid form of SARM (NM_015077.2). Thus, the actual full length SARM 
is 724 amino acids and not 690 amino acids. The N-terminus of SARM 
690 (~100 amino acids) is different from that of SARM 724 (Figure 4.3). 
However, the rest of the SARM 690 sequence is exactly homologous to 
that of SARM 724. In this study, we have used only the SARM 724, 
which we named as SARM FL (FL for full length). 
  
SARM724        MVLTLLLSAYKLCRFFAMSGPRPGAERLAVPGPDGGGGTGPWWAAGGRGPREVSPGAGTE  60 
SARM690        ----------MGAVARAHGGLRVARARESVAGGRHRGAGRPGARAAG------------- 
                           .   *  * *    * .* *    *   *   * *                                                                        
SARM724        VQDALERALPELQQALSALKQAGGARAVGAGLAEVFQLVEEAWLLPAVGREVAQGLCDAI   120 
SARM690        -------AAAGLVRAEAGGRRAGRGRRPGRGLPTGG----GGLAAAAVGREVAQGLCDAI 
                      *   * .* .  ..**  *  * **              ************** 
       ARM 1 
SARM724        RLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVARIGLGVILNLAKEREPVEL   180 
SARM690        RLDGGLDLLLRLLQAPELETRVQAARLLEQILVAENRDRVARIGLGVILNLAKEREPVEL 
               ************************************************************ 
                                           ARM 2 
SARM724        ARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQA   240 
SARM690        ARSVAGILEHMFKHSEETCQRLVAAGGLDAVLYWCRRTDPALLRHCALALGNCALHGGQA 
               ************************************************************ 
 
SARM724        VQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLV   300 
SARM690        VQRRMVEKRAAEWLFPLAFSKEDELLRLHACLAVAVLATNKEVEREVERSGTLALVEPLV 
               ************************************************************ 
 





SARM690        ASLDPGRFARCLVDASDTSQGRGPDDLQRLVPLLDSNRLEAQCIGAFYLCAEAAIKSLQG 
               ************************************************************ 
                                                                    
SARM724        KTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTW   420 
SARM690        KTKVFSDIGAIQSLKRLVSYSTNGTKSALAKRALRLLGEEVPRPILPSVPSWKEAEVQTW 
               ************************************************************ 
 
SARM724        LQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYS   480 
SARM690        LQQIGFSKYCESFREQQVDGDLLLRLTEEELQTDLGMKSGITRKRFFRELTELKTFANYS 
               ************************************************************ 
                               SAM 
SARM724        TCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILT   540 
SARM690        TCDRSNLADWLGSLDPRFRQYTYGLVSCGLDRSLLHRVSEQQLLEDCGIHLGVHRARILT 
               ************************************************************ 
                                                
SARM724        AAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEA   600 
SARM690        AAREMLHSPLPCTGGKPSGDTPDVFISYRRNSGSQLASLLKVHLQLHGFSVFIDVEKLEA 
               ************************************************************ 
                               TIR 
SARM724        GKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGF   660 
SARM690        GKFEDKLIQSVMGARNFVLVLSPGALDKCMQDHDCKDWVHKEIVTALSCGKNIVPIIDGF 
               ************************************************************ 
 
SARM724        EWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSSRDSSAGSDTSLEGAAP   720 
SARM690        EWPEPQVLPEDMQAVLTFNGIKWSHEYQEATIEKIIRFLQGRSSRDSSAGSDTSLEGAAP 
               ************************************************************ 
SARM724        MGPT                                                           724              
SARM690        MGPT 
               ***   
 
Figure 4.3: The N-terminus of SARM 690 is different from SARM 724. 
Pairwise alignment of SARM 690 and SARM 724 (ClustalW). The non-
homologous region is boxed. “Asterisk” and “dot” indicate positions, which 
have a fully conserved residue and conservation between residues of weakly 
similar properties respectively. All the three major domains of SARM- ARM, 
SAM and TIR are highlighted with yellow, green and pink color respectively.  
 
4.2. Mitochondrial localization of SARM 
As described in section 1.5.3.1, the exact subcellular localization of 





localization of SARM might offer insights into its functional role. 
Hence we designed experiments to study the exact subcellular 
localization of SARM. We performed immunofluorescence, subcellular 
organelle fractionation study and electron microscopy to clearly 
understand the exact subcellular localization of SARM 
(Panneerselvam, 2012b).   
 
4.2.1. SARM FL GFP specifically colocalizes with mitochondria but  
          not with endosomes 
We primarily studied the intracellular localization of SARM in primary 
murine T cells. Upon nucleofection of the activated T cells with SARM 
FL-GFP fusion construct, we observed that the majority of SARM co-
localized with the mitochondria (Figure 4.4A). For clearer visualization 
of SARM-mitochondrial association we used two model cell lines - 
HEK 293T and NIH 3T3 cells. Co-staining the transfected HEK 293T 
cells with mitotracker or endosomal marker (transferrin) confirmed 
SARM-mitochondrial association. Confocal microscopy clearly 
revealed that SARM was associated with the mitochondria and not 






Figure 4.4: SARM FL GFP specifically colocalises with mitotracker. (A) 
Activated primary CD8 T cells were nucleofected with SARM FL EGFP fusion 
construct. 6 h later, the cells were stained with mitotracker, fixed and 
observed under fluorescence microscope. Scale bar is 10 m. (B) HEK 293T 
cells were transfected with full-length SARM FL EGFP (FL) fusion construct. 
At 12 h post-transfection, cells were co-stained with mitotracker 
(mitochondria) or transferrin (endosomes). Scale bar is 5 m. 
 
 
Mitochondrial localization of SARM FL was further confirmed in 
another cell line, NIH 3T3 (Figure 4.5A). Additionally SARM FL 





(Figure 4.5B). Thus, it is evident that SARM is specifically localized in 
the mitochondria.  
 
Figure 4.5: SARM specifically colocalizes with the mitochondrial protein 
cytochrome c. (A) At 12 h post-transfection, NIH 3T3 cells transfected with 
full-length SARM (FL) were co-stained with mitotracker. The cells were fixed 
and observed under confocal microscope. (B) NIH 3T3 cells transfected with 
SARM (FL) were fixed, permeabilised and stained with anti-cytochrome c 
(mitochondrial protein). The cells were then viewed under confocal 
microscope. Scale bar: 5 m. 
 
4.2.2. SARM is enriched in the mitochondrial fraction of both HEK  
          293T and primary cytotoxic T cells 
The mitochondrial localization of SARM was further confirmed 
biochemically by isolating the mitochondrial fraction from primary 
cytotoxic T cells. Mitochondrial fractions were obtained by differential 





fraction. Immunoblots with mitochondria and cytosol specific markers 
revealed that the subcellular fractions were pure (Figure 4.6A). The 
mitochondrial fraction was enriched from untransfected and SARM-
transfected HEK 293T cells. Both endogenous and transiently 
expressed SARM were enriched in the mitochondrial fraction (Figure 
4.6B).    
 
Figure 4.6: SARM is specifically enriched in the mitochondrial fraction. (A) 
Mitochondria were isolated from primary T cells by differential 
centrifugation. Mitochondrial (Mito) and cytoplasmic (Cyto) fractions were 
blotted and probed with anti-SARM. The membrane was probed with anti-
VDAC, a mitochondria marker and anti-GAPDH, a cytosol marker. (B) 
Mitochondria (Mito) and cytosolic (Cyto) fractions were isolated from 
untransfected and SARM-EGFP (FL) transfected HEK 293T cells by 
differential centrifugation. Lysates were immunodetected with anti-SARM 
and anti-EGFP, respectively. The same membrane was stripped and reprobed 
with anti-VDAC and anti-GAPDH that served as mitochondrial and cytosolic 
markers, respectively. 






4.2.3. TEM confirms the mitochondrial localization of SARM  
 
 
Figure 4.7: TEM confirms the mitochondrial localization of SARM.  (A) 
HEK 293T cells expressing SARM FL were embedded in LR white resin and 
cut into ultrathin sections. The sections were then stained with anti-GFP 
followed by incubation with 10 nm gold-conjugated anti-rabbit secondary 
antibody. Yellow arrows point to the gold particles. The sections were then 
observed under transmission electron microscope. (B) Control untransfected 
HEK 293T cells were embedded in LR white resin and cut into ultrathin 
sections. The sections were then stained with anti-GFP followed with 10 nm 
gold-conjugated anti-rabbit secondary antibody. The sections observed under 
transmission electron microscope showed no gold particles in the 







We further performed transmission electron microscopy (TEM) to 
confirm the exact intracellular localization of SARM. Immunogold 
labeling against GFP tag indicated that SARM is specifically localized 
in the mitochondria (Figure 4.7A). The untransfected negative control 
did not show any specific gold particle inside the mitochondria (Figure 
4.7B)  
 
4.3. Mitochondria-targeting signal sequence of SARM  
Having observed that SARM specifically localized to mitochondria, we 
proceeded to define the critical region and residues that are important 
for mitochondria targeting. To study this, we tested the mitochondria 
targeting ability of several truncated and mutated constructs of SARM.  
 
4.3.1. The N terminus of SARM is important for mitochondrial  
           localization 
We attempted to locate the mitochondria-associating domain of SARM 
by immunofluorescence and found that SARM subclones lacking the 
N-terminus (SARM AST, ST and TIR) did not associate with the 
mitochondria (Figure 4.8A). Interestingly, SARM ∆TIR (SARM 
construct lacking the TIR domain at the C terminus) was associated 





and how the N-terminus of SARM might be responsible for the 
mitochondria-associating ability. To achieve this, we further subcloned 
the first 234 (N-terminus and both the ARM domains) and 124 (only 
the N-terminus) amino acids of SARM in fusion with GFP (Figure 
4.8C). Both SARM 234 (Figure 4.8D) and N124 (Figure 4.8E) became 
associated with the mitochondria in the activated cytotoxic T cells and 
HEK 293T cells. This data clearly demonstrate that the N terminal 







Figure 4.8: N terminus of SARM is important for the mitochondrial 
localization. Fluorescence localization of (A) SARM AST, SARM ST, and 
SARM TIR and (B) SARM ∆TIR GFP fusion constructs at 12 h post-
transfection with mitotracker. (C) Graphical map of N124, SARM 234 and 
SARM ∆TIR. Fluorescence colocalization of (D) SARM 234 and (E) N124-GFP 
fusion constructs with mitotracker in primary T cells and HEK 293T cells. 
Scale bar is 5 m. 
 
 
4.3.2. The ARM domain is not important for mitochondrial  
           localization  
Earlier, the ARM domain of SARM was reported to be important for its 
localization (Kim et al., 2007; Yuan et al., 2010), hence we moved on to 





made various constructs of SARM encompassing the N terminal 
domain and the two ARM domains of SARM (Figure 4.9A). In our 
analysis, we observed that only the constructs with N-terminal 124 
amino acids of SARM, the N ARM1, N ARM2 and N124 showed 
association with the mitochondria (Figure 4.9B). The ARM1 ARM2 
construct, lacking the N-terminal 124 amino acids, did not localize to 
the mitochondria (Figure 4.9B). The mitochondrial localization of N124 
was further confirmed biochemically by isolating the mitochondrial 
fraction from N124- transfected HEK 293T cells. N124 protein was also 
specifically detected in the mitochondrial fraction of the transfected 
cells. Immunoblots with mitochondria- and cytosol- specific markers 
revealed that the subcellular fractions were pure (Figure 4.9C). The 
mitochondrial association of N ARM1, N ARM2 and N124 was further 
validated in another cell line, NIH 3T3 cells (Figure 4.9D). 
Additionally, N124 specifically co-localized with the mitochondrial 
protein, cytochrome c, in NIH 3T3 cells (Figure 4.9E). Collectively, it is 
evident that the N-terminal domain and not the ARM domain of 
SARM, is important for mitochondrial association. Hence it was 
imperative to delineate the exact sequence at the N-terminal domain of 






Figure 4.9: ARM domain is not important for mitochondrial localization of 
SARM. (A) Graphical map of N124, N ARM1, N ARM2 and ARM1 ARM2 in 
SARM. (B) At 12 h post-transfection, HEK 293T cells transfected with N 
ARM1, N ARM2, N124 and ARM1 ARM2 -EGFP fusion constructs were co-
stained with mitotracker (mitochondria). The cells were fixed and then 
viewed under confocal microscope. (C) Mitochondria (Mito) and cytosolic 
(Cyto) fractions were isolated from N124-EGFP transfected HEK 293T cells. 
The Mito and Cyto fractions were isolated by differential centrifugation and 
lysates were immunodetected with anti-EGFP. The same membrane was 
stripped and reprobed with anti-VDAC and anti-GAPDH that served as 
mitochondrial and cytosolic markers, respectively. (D) At 12 h post- 
transfection, NIH 3T3 cells transfected with N ARM1, N ARM2, N124 and 
ARM1 ARM2-EGFP fusion constructs were co-stained with mitotracker. The 
cells were fixed and observed under confocal microscope. (E) NIH 3T3 cells 
transfected with N124 EGFP were fixed, permeabilised and stained with anti-
cytochrome c (mitochondrial marker). The cells were then viewed under 





4.3.3. The first 30 amino acids of SARM harbors structural features   









Figure 4.10: The N-terminus of SARM harbors structural features for 
mitochondrial targeting. (A) Mitochondria-targeting signal sequence of 
Superoxide dismutase, Aldehyde dehydrogenase, Cytochrome c oxidase IV 
and SARM highlighting the hydrophobic (underlined), basic (*) and hydroxy 
() side chain residues. (B) Hydropathy plot was drawn for the first 30 amino 
acids of SARM based on the hydrophobicity score obtained from ProtScale 
online server (http://web.expasy.org/protscale) using Kyte and Doolittle 
amino acid scale value. (C) Isoelectric points of sequential 30-amino acid 
segments of various SARM homologues highlight the conserved polybasic 
domain at the N-terminus. The isoelectric point was computed using an 
online expasy server (http://web.expasy.org/compute_pi/). (D) The 
secondary structure of SARM is predicted using PSIPRED 
(http://bioinf.cs.ucl.ac.uk/psipred/). The figure depicts the secondary 
structure of the first 80 amino acids of SARM, indicating that the N terminal 
of SARM (amino acids 2-16) is able to form an alpha helix. Conf – confidence, 
Pred – prediction and AA – amino acid. (E) The helical wheel projection of 
the mitochondria-targeting signal sequence of Superoxide dismutase, 
Aldehyde dehydrogenase, Cytochrome c oxidase IV and SARM was plotted 
using software 
(http://cti.itc.virginia.edu/~cmg/Demo/wheel/wheelApp.html). The 
nonpolar, polar uncharged and basic residues are indicated as orange, green 
and blue, respectively. All the indicated mitochondrial leader sequences form 
amphiphilic alpha helix except for the S27 of SARM. (F) The N terminal 27 
amino acids of various SARM homologues were aligned using ClustalX 
program. *(asterisk), :(colon), . (period) indicate conservation of the same 
single amino acid, between groups of strongly similar properties and 
between groups of weakly similar properties, respectively. 
 
We then checked whether the N-terminus of SARM could act as a 
mitochondria-targeting signal sequence. Interestingly, the N-terminus 
of SARM does not bear any sequence similarity with other reported 
mitochondria-targeting signal sequence, which could explain why Kim 
et al (Kim et al., 2007) construed the lack of a mitochondria signal 
sequence in SARM (Figure 4.10A). Then we checked if the N-terminal 





reported mitochondria signal sequence. Firstly, using Kyte-Doolittle 
hydropathy plot (Kyte and Doolittle, 1982), we found that the N-
terminus of SARM harbors a significant hydrophobic patch (Figure 
4.10B). Secondly, we observed the presence of a conserved polybasic 
domain (Figure 4.10C, (Peng et al., 2010)). Hence, the first 27 amino 
acids of SARM (S27) possess hydrophobic (Leucine and Alanine), 
positively charged (Lysine and Arginine) and hydroxylated (Serine 
and Theronine) amino acids (Figure 4.10A), which appear to bear 
resemblance to other mitochondria-targeting leader sequences (Claros 
and Vincens, 1996). Additionally, PSIPRED (McGuffin et al., 2000) 
indicated that S27 (amino acids 2-16 of SARM) has the ability to fold 
into an alpha helix (Figure 4.10D). However the alpha helix is not 
amphiphilic as indicated by a helical wheel analysis 
(http://rzlab.ucr.edu/scripts/wheel/wheel.cgi) (Figure 4.10E). Thus, 
except for the lack of a typical alpha helix motif with amphiphilicity, it 
appears evident that the first 27 amino acids of SARM resemble a 
mitochondria-targeting signal sequence (Figure 4.10E). However, 
amphiphilicity has been considered not essential in some 
mitochondria-targeting sequences (Allison and Schatz, 1986; Horwich 





hypothesized that the first 27 amino acids of SARM might be 
important for its association with the mitochondria. Coincidentally, we 
noted that the first 27 amino acids of SARM are well conserved across 
various SARM homologues (Figure 4.10F), suggesting a potential 
functional significance. 
 
4.3.4. S27 peptide directly binds to lipids and mitochondria 
SVMPROT (http://jing.cz3.nus.edu.sg/ cgi-bin/ svmprot. cgi) 
predicted SARM to be a lipid binding protein. Hence we reasoned that 
the direct lipid binding ability of S27 might aid in the mitochondrial 
import of SARM. Hence, we assessed the ability of the leading 27 
amino acids of SARM to associate with lipids. To achieve this, we 
chemically synthesized S27 peptide. The S27 peptide possesses one 
Tyrosine and two Phenylalanine residues (Figure 4.11A). The presence 
of Tyrosine conferred fluorescence property to S27 peptide, which 
made it possible to measure its interaction with lipids. Interestingly, in 
the presence of POPC:POPG (at a ratio of 2:1 lipid suspension of POPC 
- Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, POPG - Palmitoyl-2-
oleoyl-sn-glycero-3-Phospho-rac-(1-glycerol) (sodium salt)), the 





indicating potential interaction between the S27 and lipid (Figures 
4.11B and 4.11C). The control peptide, negS1, which possesses a 
Tryptophan residue (measured at λex 280 nm) did not show any 
significant change in the inherent fluorescence emission in the presence 
of POPC:POPG (Figure 4.11D). Furthermore, the TMR-labeled S27 
peptide showed preferential binding to POPG compared to POPE 











Figure 4.11: S27 peptide associates with lipids and mitochondria. (A) 
Amino acid sequence of S27 highlighting the residues (Tyrosine – Y and 
Phenylalanine – F) which contributes to the intrinsic fluorescence property of 
the peptide. (B) The Tyrosine fluorescence emission spectrum of S27 peptide 
with increasing concentrations of POPC:POPG (0, 50, 100, 250, 500 µM). (C) 
The Tyrosine fluorescence emission of S27 peptide at 303 nm was measured 
with increasing concentrations of POPC:POPG (0, 50, 100, 250 µM). Data 
represent means  standard deviations of triplicate measurements. (D) The 
Tryptophan fluorescence emission spectrum of negS1 control peptide 
measured with increasing concentrations of POPC:POPG (0, 50, 100 and 250 
µM) showed no significant difference in the fluorescence emission, indicating 
that it does not interact with lipids. (E) Solid phase interaction of S27 with 
POPE and POPG. Equal amounts of POPE and POPG were dot-blotted on 
PVDF membrane and incubated with S27-TMR. The fluorescence emission 
was measured at λex 495 nm/ λem 525 nm. Mitochondria were isolated from 
HEK 293T cells by differential centrifugation following the manufacturer’s 
protocol and incubated in the dark with indicated amounts of the labeled 
peptide. Labeled mitochondria were then washed and analyzed by flow 
cytometry. (F) Representative flow cytometry data depicting the overlay of 
mitochondrial fluorescence of unlabelled (grey) and peptide incubated 
mitochondria (black). (G) Bar chart indicating the proportion of mitochondria 
labeled with S27-TMR with increasing amounts of peptide. Data represent 
means  standard deviations of triplicate measurements. 
 
It is noteworthy that POPG is predominantly found in bacterial cell 
wall while POPE is present in the mammalian cell membrane (Li et al., 
2006). As the mitochondria are evolutionary endosymbionts of 
bacterial origin, POPG is present in the mitochondrial membrane lipids 
(Dolezal et al., 2006; van Meer et al., 2008). Therefore, the stronger 
association of S27 to POPG corroborates the preferential anchorage of 
S27 on the mitochondrial membrane lipid. To substantiate our finding 
that S27 peptide associates with the mitochondrial membrane, we 





centrifugation. When S27-TMR was incubated with the isolated 
mitochondria, we observed a dose-dependent increase in the binding 
of the S27 peptide to the cell-free mitochondria (Figures 4.11F and G). 
Taken together, our results showed that the N-terminal 27-amino acid 
leader sequence of SARM could potentially interact with lipids, in 
particular, with the mitochondrial membrane lipids. 
 
4.3.5. S27 is sufficient to target EGFP to the mitochondria 
The ability of S27 to act as a mitochondria-targeting signal sequence 
was then directly visualized in a live cell. We prepared two different 
fluorescent fusion constructs of S27, one with C-terminal EGFP fusion 
(S27-EGFP) and the other with N-terminal EGFP fusion (EGFP-S27) 
(Figure 4.12A). The transfected HEK 293T cells were co-stained with 
mitotracker and endosomal marker. Confocal microscopy revealed that 
S27-EGFP was co-localized with the mitochondria but not with the 
endosomes (Figure 4.12B). Thus S27 specifically directs the EGFP to 
the mitochondria. On the contrary, the EGFP-S27 did not associate 
with the mitochondria; instead it was distributed throughout the cell 
(Figure 4.12C). Consistently, S27-EGFP was specifically detected in the 





EGFP also co-localized with mitochondria and cytochrome c in NIH 
3T3 cells (Figures 4.12E). Thus, it appears that S27 is a specific 











Figure 4.12: S27 is sufficient to target EGFP to the mitochondria. HEK 293T 
cells were transfected either with (A) S27-EGFP or EGFP-S27 fusion 
constructs. At 12 h post-transfection, S27-EGFP transfected cells were co-
stained with either (B) mitotracker (mitochondria) or labeled transferrin 
(endosomes). The cells were fixed and then viewed under confocal 
microscope. (C) Similarly, EGFP-S27 transfected cells were labeled with 
mitotracker and viewed under confocal microscope. (D) Mitochondria (Mito) 
and cytosolic fractions (Cyto) were isolated from S27-EGFP transfected HEK 
293T cells by differential centrifugation and lysates were Western blotted 
with anti-EGFP. The same membrane was stripped and reprobed with anti-
VDAC and anti-GAPDH, which served as mitochondrial and cytosolic 
markers, respectively. (E) At 12 h post-transfection, NIH 3T3 cells transfected 
with S27-EGFP fusion construct were co-stained with mitotracker 
(mitochondria) or permeabilised and stained with anti-cytochrome c 
(mitochondrial marker). The cells were fixed and observed under confocal 
microscope. Scale bar: 5 m. 
 
4.3.6. TEM confirms that S27 is the mitochondria-targeting signal  
          sequence of SARM  
We further performed transmission electron microscopy (TEM) to 
confirm the specificity of S27 as a mitochondria targeting signal 
sequence. HEK cells transfected with S27-EGFP was used for TEM 
studies. Immunogold labeling against EGFP tag showed that EGFP 
was specifically localized inside the mitochondria. The untransfected 
negative control did not show any gold particle in the mitochondria 
(Figures 4.13A and B). To further confirm the specific localization of 
S27-EGFP in the mitochondria, we performed double labeling of S27-
EGFP with mitochondrial matrix protein, Pyruvate Dehydrogenase 





EGFP with the matrix protein, PDH E1 (Figure 4.13C). Hence, it 
appears that S27 specifically targets and translocates the EGFP into the 
mitochondrial matrix and we have delineated SARM S27 leader 











Figure 4.13: TEM confirms that S27 is a unique mitochondria-targeting 
signal sequence. HEK 293T cells transfected with S27-EGFP fusion construct 
were embedded in LR white resin. Transmission electron micrograph of (A) 
untransfected or (B) S27-EGFP expressing HEK 293T cells. Ultrathin sections 
were labeled with rabbit anti-EGFP followed by labeling with 10 nm gold 
conjugated anti-rabbit secondary antibody. Yellow arrows point to 10 nm 
gold particles. N denotes Nucleus. Scale bar: 0.2 m. (C) Ultrathin gold 
sections of embedded S27-EGFP transfected HEK 293T cells were stained 
with mouse anti-PDH E1 and rabbit anti-EGFP. The sections were then 
stained with 10 nm gold conjugated anti-mouse and 20 nm gold conjugated 
anti-rabbit secondary antibodies. N denotes Nucleus. Scale bar: 100 nm. 
Following immunogold labeling, the sections were stained with Osmium 
chloride, Lead citrate and Uranyl acetate. The grids containing the sections 
were then observed using JEM 1010 TEM. Regions of the cell that are shown 
at higher magnification are marked with boxes. 
 
 
4.3.7. Arginine14 is the critical determinant of mitochondrial  
           localization 
We then delineated the key residue(s) in S27 that might be 
determinant(s) for the mitochondrial targeting. Guided by the 
hypothesis that basic residues might be important for mitochondrial 
import, we mutated Lysine11, and Arginine14, 22 and 27 to Alanine 
(Figure 4.14A). The HEK 293T cells transfected with these mutant 
constructs (Lys11Ala, Arg14Ala, Arg22Ala and Arg27Ala) were stained 
with mitotracker to observe potential co-localization. All the mutants 
except Arg14Ala retained their ability to localize to the mitochondria 
(Figure 4.14B). Interestingly mutation of only the Arginine14 abolished 





single residue for translocating the protein into the mitochondria 
(Figure 4.14B). 
 
The critical role of Arg14 in determining the mitochondrial localization 
was further confirmed by transfecting each of the four mutant 
constructs into NIH 3T3 cells. Consistently, the Arg14Ala mutant failed 











Figure 4.14: Arginine14 is critical for mitochondrial localization. (A) Amino 
acid sequence of S27 highlighting the basic residues that are mutated. (B) 
HEK 293T cells grown on the glass cover slip were transfected with S27-EGFP 
mutant plasmids: Arg14Ala, Lys11Ala, Arg22Ala and Arg27Ala. At 12 h post-
transfection, cells were co-stained with mitotracker (Mitochondria). The cells 
were fixed and then viewed under confocal microscope. (C) At 12 h post-
transfection, NIH 3T3 cells transfected with S27-EGFP mutant constructs: 
Arg14Ala, Lys11Ala, Arg22Ala and Arg27Ala were co-stained with 
mitotracker (mitochondria). The cells were fixed and observed under confocal 
microscope. Except for R14A mutant, all other mutants (Lys11Ala, Arg22Ala 
and Arg27Ala) associate with mitochondria in both HEK 293T and NIH 3T3 
cells. Scale bar: 5 m. 
 
4.4. Hallmark apoptotic features displayed by SARM expressing cells 
The functional characterization of SARM was studied in parallel with 
the subcellular localization study. During our preliminary attempts to 
explore the function of SARM in T cells, we observed that over 
expression of SARM caused increased proportion of propidium iodide 
stained cells when compared to control transfected cells (Figure 4.15).  
Thus, we specifically focused our attention to study cell death pathway 
induced by SARM. To enable our study, apart from primary T cells we 
also employed various model cell lines namely HEK 293T, HEK Bcl-xL, 





    
Figure 4.15: SARM induced cell death in primary T cells. Activated primary 
CD8 T cells were nucleofected with either EGFP or SARM. 24 h post 
transfection, the cells were stained with propidium iodide and cell death was 
assessed by flow cytometry. FACS plot indicate greater proportion of PI 
positive SARM transfected cells. 
 
 
4.4.1. SARM induces apoptosis in HEK 293T model cell line - ST  
           (SAM and TIR) is the proapoptotic functional domain 
 
As described in section 1.5.3, SARM is a multi-domain protein. Hence, 
to examine the proapoptotic functional role of SARM, we made various 
truncated constructs of SARM encompassing different domains (Figure 
4.16). 










Firstly we checked the expression competency of all the truncated 
constructs in HEK 293T. HEK 293T cells were transfected with different 
truncated construct and cell lysates were prepared for Western blot 
analysis. Western blot indicated that all the constructs were expression 
competent, producing truncated SARM proteins of the expected 
molecular weight (Figure 4.17).           
                                  
Figure 4.17: Expression of various SARM truncated constructs. Cell lysates 
from 24 h post-transfection of various truncated constructs of SARM were 
immunoblotted with anti-GFP. The membrane was stripped and reprobed 
with anti β-actin. 
 
To assess the proapoptotic effect of SARM, HEK 293T cells were 
transfected with the indicated truncated constructs of SARM. 
Following transfection, the cells were stained with 7-AAD exclusion 
dye and cell death was quantified by flow cytometry. We observed 
greater than 50% cell death in SARM FL (Full length)-expressing cells 





various time points post-transfection indicated progressive cell death 
in the case of SARM FL, SARM AST (ARM, SAM and TIR domains) 
and SARM ST (SAM and TIR domains) (Figure 4.18). The truncated 
construct, SARM ST, induced cell death similar to that of SARM FL, 
suggesting that the SAM and TIR domains might be responsible for the 
induction of apoptosis. 
                                               
Figure 4.18: Induction of cell death by SARM in HEK 293T cells. HEK 293T 
cells in 12-well plate were transfected with 800 ng of the indicated GFP fusion 
construct. Cell death was quantified by dead cell exclusion test using 7-AAD. 
GFP transfected cells were used as negative control. This experiment was 
repeated for three independent times. Data represent means ± SD of at least 
two independent experiments.     
 
4.4.2. Expression of SARM ST exhibited hallmark apoptotic features   
           in transfected cells 
Having observed that SARM induces cell death, it was pertinent for us 





features. Expression of SARM ST in HEK 293T cells exhibited key 
apoptotic features like nuclear condensation, nuclear fragmentation 
and cell shrinkage. DAPI staining of the transfected cells indicated 
nuclear condensation. TUNEL (Terminal deoxynucleotidyl transferase) 
assay detected nuclear fragmentation by incorporation of TMR labeled 
dUTP (Figure 4.19). 
 
Figure 4.19: SARM ST expression exhibited hallmark apoptotic features (A) 
White arrow indicates that SARM ST-transfected cells at 24 h post-
transfection show distinctive morphological rounding up compared to GFP-
transfected controls. (B) Nuclear condensation of SARM ST-transfected cells 
was visualized by DAPI staining. SARM ST-GFP positive cells in 20 random 
microscopic fields were enumerated and the percentage was calculated based 
on GFP-positive transfected cells. Data represent means ± SD of three 
independent experiments. *p<0.005. (C) At 24 h post-transfection, the 
fragmented nuclei were quantified by labeling the nicked ends of the DNA by 
TUNEL Assay. DNase I-treated cells were used as positive control. 
 
Furthermore, FACS analysis of SARM ST-transfected cells double-
stained with cell-permeable and cell-impermeable nuclear dyes, 





condensation occurred before the cell membrane was compromised 
(Figure 4.20). Collectively, it is evident that SARM induces cell death 
by exhibiting hallmark apoptotic features. 
 
                          
Figure 4.20: Chromatin condensation occurs before cell membrane is 
compromised. SARM ST-transfected cells at 12 h post transfection were 
double-stained with Hoechst and Propidium iodide to study cell membrane 
integrity and condensation of the nuclei. 
 
4.4.3. SARM ST potently induces cell death in primary cytotoxic T  
           cells 
 
Next, we examined whether SARM executes a similar death-inducing 
function in primary cytotoxic T cells. Simultaneously, we nucleofected 
various truncated SARM-GFP fusion constructs into activated CD8 T 
cells. We observed that expression of SARM AST or SARM ST in CD8 
T cells induced > 80% cell death, higher than that induced by SARM FL 
(Figure 4.21A). Notably, the cytotoxic effect of SARM AST and SARM 





SARM ST-expressing cells started to die as early as 3 h post-
nucleofection, and by 24 h almost 90% of the cells were non-viable 
(Figure 4.21B). 
 
Figure 4.21: Over expression of SARM induces apoptosis in primary 
cytotoxic T cells (A) Activated primary CD8 T cells were nucleofected with 4 
g of truncated SARM constructs. Cell death was quantified 24 h post-
nucleofection by 7-AAD staining. This experiment was repeated for three 
independent times. (B) Kinetic profile of primary CD8 T cell death following 
nucleofection with SARM ST compared to GFP alone cells. Data in (A) 
















4.4.4. The proapoptotic functional role of SARM is conserved in  
           different cell types 
SARM is evolutionarily well conserved (Figure 1.15). So we speculated 
that its proapoptotic role is not confined to only T cells. Kim et al 
reported that SARM is expressed in neurons and B cells apart from T 
cells (Kim et al., 2007). Moreover, global gene expression profile 
indicated that SARM is downregulated in NK/T cell lymphoma biopsy 
tissues when compared to healthy NK cells (Ng et al., 2011). Hence we 
examined the effect of SARM expression in Neuro-2a (a neuroblastoma 
cell line), Raji B (a burkitt lymphoma cell line) and NK-YS (a human 
NK/T cell lymphoma derived cell line) cells. We confirmed the 
expression of SARM in these cell lines by reverse transcriptase PCR. 
We demonstrated that SARM plays a similar proapoptotic role in all 
the three cell lines studied (Figure 4.22). These data collectively suggest 






Figure 4.22: The proapoptotic role of SARM is conserved in different cell 
types. PCR was carried out using cDNA prepared from RNA isolated from 
(A) mouse Neuro-2a cells. RT PCR specifically amplified a 125-bp product 
corresponding to endogenous SARM. (B) Neuro-2a cells were nucleofected 
with GFP or SARM FL or SARM ST. Cell death was quantified at 12 h post-
nucleofection by staining the cells with the dead cell stain, 7-AAD. (C) RT 
PCR specifically amplified a 465-bp product corresponding to endogenous 
SARM in the cDNA prepared from NK-YS and Raji B cells. (D) Raji B and (E) 
NK-YS cells were nucleofected with GFP or SARM FL or SARM ST. At 12 h 
post-nucleofection, the cells were stained with 7-AAD and cell death was 












4.4.5. GFP fusion does not affect the proapoptotic function of SARM  
           ST 
To exclude the possibility that GFP fusion might be responsible for cell 
death, we cotransfected the individual deletion constructs of SARM 
and GFP in the molar ratio of 5:1, and showed that the SARM ST:GFP 
coexpressing cells exhibited lower GFP mean fluorescence intensity 
when compared to the control, indicating that SARM ST mediates cell 
death. Consistently, the trypan blue dye exclusion test showed more 
dead cells with SARM ST. When cells were cotransfected with GFP 
plus increasing amounts of SARM ST, we observed a dose-dependent 
decrease in the mean fluorescence intensity, suggesting the specificity 
of the observed SARM-mediated cell death (Figure 4.23). These data 










Figure 4.23: GFP fusion does not affect the proapoptotic function of SARM. 
HEK 293T cells were cotransfected with pCDNA/ SARM ST/ SARM TIR and 
GFP in the ratio of 5:1 each. (A) At 24 h post-transfection, GFP-positive cells 
were analyzed by flow cytometry. Flow cytometry indicates the altered GFP 
expression in SARM ST transfected cells. (B) Percentage of GFP-positive cells 
(GFP+) and (C) Mean GFP fluorescence intensity was measured by flow 
cytometry at 12, 24, 36 and 48 h post-transfection for each of the SARM 
constructs. (D) Dead cells were stained with trypan blue dye and enumerated 
using a Neubauer hemocytometer chamber. (E) HEK 293T cells were 
transfected with varying ratios of GFP:SARM (1:1, 1:2, 1:3, 1:4, 1:5) and at 24 h 
post-transfection, the mean fluorescence intensity was measured by flow 
cytometry. The total amounts of the recombinant plasmid DNA were 
balanced with pCDNA vector.  
 
4.5. How does SARM induce apoptosis? 
Following our observation that SARM is proapoptotic, it was 
important to determine the detailed mechanism of SARM induced 





SARM-induced apoptosis. Figure 4.24 highlights the two major 
apoptotic pathways and key molecular players involved. 
 
Figure 4.24. Extrinsic and Intrinsic apoptotic pathways. Schematic 
representation of key molecular players involved in intrinsic and extrinsic 
apoptotic pathway.   
 
4.5.1. SARM mediates apoptosis via initiator caspase-9  
To further confirm that SARM induces apoptosis, we investigated 
caspase activities. The SARM FL- and SARM ST-transfected HEK 293T 
cells were loaded with cell permeable fluorogenic caspase-3 substrate 
to examine the potential involvement of caspase-3. The proportion of 





increased significantly over 18-24 h (Figure 4.25A). Subsequently, we 
observed that around 35% of SARM FL expressing T cells showed 
significant increase in caspase-9 activity (Figure 4.25B). Furthermore, 
we examined the potential activation of caspases 3, 9 and 8 in SARM 
ST-expressing CD8 T cells. Flow cytometry indicated a dynamic 
increase in the proportion of cells positive for active caspases 3, 9 and 8 
(Figure 4.25C). Within 3 h post-nucleofection, a higher proportion of 
cells were active for caspase-9 relative to caspase-3 and -8 (caspase-3, 
23.18±4.2%; caspase-8, 18.4±2.8%; caspase-9, 38.34±2.6%) (Figures 
4.25C-F). At 24 h, fewer cells exhibited caspase-8 activity (51.2±5.6%) 
than caspase-3 (75.52±0.44%) and caspase-9 (80.58±1.6%) (Figures 
4.25C-F). Hence, the order and level of activation was caspase-9 > 
caspase-3 > caspase-8, supporting that SARM induces apoptosis 
primarily via the intrinsic pathway. Corroborating our observation, 
caspases-9 and -3 have been reported to activate caspase-8 during the 
amplification of apoptosis (Viswanath et al., 2001; Yang et al., 2006). It is 
likely that during T cell clearance, caspases collaborate to ensure that 












Figure 4.25: SARM mediates apoptosis via initiator caspase-9. (A) HEK 293T 
cells were transfected with 800 ng of SARM FL/ SARM ST/ GFP plasmids. 
At 12, 18 and 24 h post-transfection, cells were loaded with fluorogenic 
caspase-3 substrate and the proportion of caspase-3 active cells was 
quantified. (B) Activated CD8 T cells expressing SARM was assessed for 
caspase-9 activities at 12 and 24 h post-nucleofection. (C) Activated primary 
CD8 T cells were nucleofected with SARM ST GFP/ GFP alone and assayed 
for caspases 9, 3 and 8 activities. Representative flow cytometry data depict 
the overlay of caspase activity histogram of SARM ST and GFP-transfected 
cells at 3 h (first 3 panels). The line graph (fourth panel) indicates the 
proportion of caspases 3, 9 and 8 active cells during the indicated time points 
of 3, 6, 12 and 24 h post-nucleofection. Activated primary cytotoxic T cells 
were nucleofected with SARM ST GFP or GFP alone and assayed for (D) 
caspase-3, (E) caspase-9 and (F) caspase-8 activities at 3, 6, 12 and 24 h post-
nucleofection. Representative flow cytometry data depicts the overlay of 
caspase activity histogram of SARM ST- and GFP- transfected cells at 
indicated time points. Data in (A), (B) and (C) represent means ± SD of three 

















4.5.2. SARM forms MPTP to mediate intrinsic pathway  
Permeabilisation of mitochondria is a major step leading to intrinsic 
apoptosis (Kroemer et al., 2007) (see Figure 4.24). Thus, we examined 
the mitochondrial permeability transition pore (MPTP) formation by 
loading the cells with a mitochondrial dye, tetra methyl rhodamine 
ester (TMRE). The HEK 293T cells expressing SARM FL, AST and ST 
consistently showed a drop in the mitochondrial transmembrane 
potential (m) indicating that MPTP is formed. The percentage of 
cells with reduced m had increased significantly with time in all 
cases except for the control GFP-transfected cells (Figures 4.26A and 
C). By 24 h post-transfection, >45% of SARM FL-, SARM AST- and 
SARM ST-expressing cells showed decreased m. This clearly 
demonstrates a dynamic increase in the mitochondrial permeability 
relative to SARM expression. Similarly, we observed a dynamic 
increase in MPTP formation in the primary CD8 T cells expressing 










Figure 4.26: SARM induces MPTP to mediate intrinsic apoptosis. (A) HEK 
293T cells transfected with SARM FL/ SARM AST/ SARM ST/GFP alone 
were loaded with 20 nM of TMRE dye at 12, 18 and 24 h post-transfection. 
Decrease in mitochondrial transmembrane potential (∆Ψm), was computed 
based on TMRE fluorescence for each of the constructs. (B) Activated primary 
CD8 T cells were nucleofected with SARM ST/ GFP and ∆Ψm was quantified 
as above.  (C) Representative flow cytometry diagram of TMRE loaded HEK 
293T cells transfected with equal amounts of SARM FL/ SARM AST/ SARM 
ST/GFP at 12, 18 and 24 h post-transfection. CCCP treated cells were used a 
positive control for mitochondrial pore formation. Data in (A) and (B) 
represent means ± SD of three independent experiments. *p<0.0005; 
**p<0.008. 






4.5.3. SARM expression generates reactive oxygen species (ROS) 
  
Figure 4.27: Killer ROS is generated in SARM transfected cells. Intracellular 
ROS was detected in HEK 293T cells transfected with SARM FL/ SARM ST, 
using CMH2DCFDA, at 12, 18 and 24 h post-transfection. (A) The proportion 
of cells with increased intracellular ROS were calculated and plotted. (B) 
Representative flow cytometry data depicts the overlay of CMH2DCFDA 
intensity histogram of SARM ST at indicated time points. Cells treated with 
H2O2, a strong oxidizing reagent to generate ROS, served as the positive 








MPTP formation results in the release of mitochondrial content into the 
cytosol. This affects the redox balance of the cell (Elmore, 2007) (see 
Figure 4.24).  Hence we measured the levels of intracellular ROS in 
SARM transfected cells. We observed ~30% increase in intracellular 
ROS in SARM FL- and SARM ST-expressing HEK 293T cells (Figure 
4.27). Thus, it appears that SARM mediates apoptosis by generating 
ROS. 
 
4.5.4. SARM mediates apoptosis via Bcl-2 family 
Bcl-2 family members primarily guard mitochondrial integrity (Cory 
and Adams, 2002). The stoichiometry between the pro- and anti-
apoptotic Bcl-2 proteins dictates the cellular commitment to apoptosis 
(Chipuk and Green, 2008) (see Figure 4.24). Hence we tested if SARM 
mediates intrinsic apoptosis by regulating the levels of Bcl-2 family 
members. 
 
4.5.4.1. SARM expression downregulated Bcl-xL but not Bcl-2 
Initially, we tested whether the levels of Bcl-2 family members might 
be affected upon SARM expression. We observed a decrease in the 





expressing primary T cells (Figure 4.28). However, the Bcl-2 levels 
were unaffected by SARM expression. Hence it is likely that SARM 
mediates apoptosis by regulating the levels of Bcl-xL, which is an anti-
apoptotic member of the Bcl-2 family, located in the outer 
mitochondrial membrane. 
                                      
Figure 4.28: SARM specifically downregulates Bcl-xL expression. Cell 
lysates were prepared from SARM FL-, SARM ST-, GFP-transfected and 
control untransfected primary CD8 T cells, and immunoblotted and probed 
with anti-Bcl-xL and anti-Bcl-2. Actin was used as the loading control. 










4.5.4.2. Bcl-xL expression hampered SARM-induced apoptosis 
To confirm that apoptosis induced by SARM is mitochondria-
mediated, we studied the effect of Bcl-xL overexpression on the 
proapoptotic function of SARM. We checked if anti-apoptotic Bcl-xL 
could oppose the proapoptotic action of SARM. We found that 
overexpression of Bcl-xL significantly reduced the SARM-induced 
apoptosis by 50% (Figure 4.29A). To further substantiate our findings, 
we examined the apoptotic effect of SARM in HEK cell line, which was 
stably expressing Bcl-xL. Western blot analysis indicated that HEK Bcl-
xL cell line (Invivogen) expressed Bcl-xL very strongly compared to the 
control HEK cell (Figure 4.29B). Both SARM FL and SARM ST 
expression in HEK Bcl-xL cell line caused 3-fold reduced cell death 
when compared to the wild type cells (Figure 4.29C). Thus it appears 
that Bcl-xL expression downregulates the proapoptotic action of 






Figure 4.29: Bcl-xL expression inhibits SARM-induced apoptosis. (A) HEK 
293T cells were cotransfected with Bcl-xL and SARM FL/SARM ST in the 
ratio of 5:1. At 24 h post-transfection, the cells were stained with 7-AAD and 
assessed for cell death by flow cytometry. (B) Immunoblot of the lysates 
obtained from HEK 293T cells and HEK Bcl-xL cells with anti-Bcl-xL. Actin 
was used as loading control. Molecular weight marker was run in between 
HEK 293T and HEK Bcl-xL cell lysates. (C) SARM FL/SARM ST was 
expressed in both HEK 293T and HEK Bcl-xL cell line. At 24h post-
transfection, cell death was assessed by counting the 7-AAD positive cells by 
flow cytometry. Data in (A) and (C) represent means ± SD of at least three 





4.5.4.3. SARM-induced MPTP is abrogated in BAX-/-BAK-/- MEF cells 
BAX and BAK are the key effector members of the Bcl-2 family that 
mediates MPTP formation by oligomerizing on the mitochondrial 
outer membrane. Hence we tested whether SARM induces MPTP 
formation via BAX and BAK. To enable our study, we used BAX BAK 
double knockout cell line (BAX-/- BAK-/- MEF cell line). Interestingly we 
observed that SARM induced MPTP is completely abrogated in BAX-/- 
BAK-/- MEF cells when compared to wild type MEF (WT MEF) (Figure 
4.30).  
                                    
Figure 4.30: SARM induced MPTP is abrogated in BAX-/-BAK-/- MEF cells. 
SARM FL/GFP was expressed in both wild type and BAX-/- BAK-/- mouse 
embryonic fibroblast cell lines. At 24 h post-transfection, decrease in 
mitochondrial transmembrane potential (∆Ψm), was computed based on 






Thus it is evident that SARM mediates intrinsic apoptosis via BAX and 
BAK, the two proapoptotic Bcl-2 family members, which are essential 
for MPTP formation. 
 
4.5.4.4. There is no direct interaction between SARM and Bcl-2  
              family members 
We then examined if SARM interacts directly with Bcl-2 family 
members (Bcl-2 and Bcl-xL), by co-immunoprecipitation (this 
experiment was performed in conjunction with Dr. Pradeepkumar 
Laishram Singh). T cell lysates prepared on day 4 post-activation was 
used for co-immunoprecipitation. Both Bcl-2 and Bcl-xl are reported to 
interact with BAX, hence BAX was employed as a positive control. 
Consistently, BAX was immunoprecipitated along with Bcl-2 and Bcl-
xL using anti-Bcl-2 and anti-Bcl-xL, respectively, suggesting that the 
co-immuprecipitation was working. However, co-
immunoprecipitation studies indicated that there is no direct 
interaction between SARM and Bcl-2/Bcl-xL (Figure 4.31). Although 
there is no direct interaction between SARM and Bcl-2 family members 





intrinsic apoptosis via Bcl-2 family members without direct physical 
interaction. 
       
Figure 4.31: SARM does not directly interact with Bcl-2 and Bcl-xL. 
Immunoprecipitation with Bcl-2 or Bcl-xL antibodies was carried out using 
primary CD8 T cell lysates. BAX, a reported interaction partner of Bcl-2 and 
Bcl-xL, was detected in both anti-Bcl-2 and anti-Bcl-xL immunoprecipitated 
products. However, SARM was not detected in the immunoprecipitated 
products of both Bcl-2 and Bcl-xL antibodies, suggesting that there is no 
direct interaction between SARM and Bcl-2 family members (Bcl-2 and Bcl-
xL). The molecular weight markers were loaded in the lane between the cell 
lysate and immunoprecipitated product lanes. 
 
4.5.5. SARM downregulates ERK phosphorylation  
Extracellular signal-regulated kinase (ERK) phosphorylation is known 
to be important for cell proliferation and differentiation (Zhang and 
Liu, 2002). ERK pathway is reported to promote cell survival in various 
cancer cells (Boucher et al., 2000; Kohno and Pouyssegur, 2006; Rasola 
et al., 2010). Hence, we tested if SARM acts by suppressing the survival 





expression substantially inhibited ERK phosphorylation (Figure 4.32). 
The suppression of pERK was much more pronounced on the 
expression of SARM ST. No change was observed with the control GFP 
expression. 
                                              
Figure 4.32: SARM downregulates the phosphorylation of ERK. Cell lysates 
were prepared from SARM FL-, SARM ST-, GFP- transfected and control 
untransfected HEK 293T cells, and immunobloted with anti-pERK. Actin was 
used as the loading control. 
 
4.6. Mitochondrial localization and ST domain are important for the  
        proapoptotic phenotype of SARM 
There is no direct link between the apoptotic phenotype of SARM to its 
mitochondrial localization so far. Hence we examined how the 








4.6.1. Arg14Ala SARM mutant displayed reduced apoptotic activity  
We have shown that Arg14 is critical for mitochondrial localization. 
Hence, we checked if mutation of Arg14 affects the pro-apoptotic 
potential of SARM. This will link the biophysical localization to the 
functional role of SARM. HEK 293T cells transfected with wild type 
SARM or Arg14Ala mutant SARM were stained with the dead cell 
stain, 7-AAD. The cell death was quantified by flow cytometry. 
Interestingly, we observed that the Arg14Ala SARM mutant lost 50% 
of its apoptotic potential compared to the wild type SARM (Figure 
4.33). This data suggests that mitochondrial localization of SARM is 
important for the proapoptotic phenotype of SARM and that a single 
point mutation can compromise the activity of SARM. Thus, we have 
also delineated the crucial role of the amino acid, Arg14, at the N-





                                     
Figure 4.33: Arg14Ala SARM mutant has reduced apoptotic activity: HEK 
293T cells in 12-well plate were transfected with either wild type SARM or 
Arg14Ala SARM mutant constructs. At 12 and 18 h post-transfection, the cells 
were stained with dead cell stain 7-AAD, and cell death was quantified by 
flow cytometry. Bar chart represents means  standard deviations of triplicate 
measurements.  *p<0.005. 
 
 
4.6.2. SARM 690, lacking the mitochondria targeting ability show    
          reduced apoptosis compared to SARM 724  
SARM 690, which was earlier, reported as SARM in PubMed, differs 
from the SARM 724 (SARM FL) only by the N terminal 100 amino acids 
containing the mitochondria targeting signal sequence (Figure 4.3) (see 
section 4.1). Thus, SARM 690 thus lacks the mitochondria targeting 
ability but possess other functional domains (ARM, SAM and TIR) 
(Figure 4.34A).  Importantly, the SARM 690 expression also induced 





data also provides additional support that the mitochondrial 
localization of SARM is attributable to the N terminal S27 present in 
SARM 724 and that it is important for its apoptotic function. 
 
 
Figure 4.34: SARM 690 that is not localized in mitochondria causes reduced 
apoptosis than SARM 724. (A) HEK 293T cells, grown on the glass coverslip, 
were transfected with EGFP plasmids fused with SARM 724 or SARM 690. At 
16 h post-transfection, the cells were co-stained with mitotracker (mito). The 
cells were then fixed and observed under confocal microscope. Scale bar is 5 
m. (B) HEK 293T cells were transfected with either SARM_724 or SARM_690 
or control GFP plasmids. The cell death was enumerated 24 h post-





4.6.3. Expression of SARM leads to mitochondrial clustering  
 
SARM expression also affected the distribution of mitochondria in the 
cell. The expression of SARM, SARM ∆TIR and SARM 234 in HEK 
293T cells altered the mitochondrial distribution, clustering this 
organelle to the perinuclear region (see figures 4.4 and 4.8). 
Subsequently, we found that although N124 (lacking the ARM 
domain), N ARM1 and N ARM2 were associated with the 
mitochondria, it did not cause mitochondrial clustering (see figure 4.9). 
Thus, it appears that both the ARM domains, present in SARM FL, 
∆TIR and 234 constructs, are necessary for mitochondrial clustering. A 
significant number of SARM 234 expressing cells exhibited 
mitochondrial clustering as early as 10 h post-transfection, which 
increased gradually with time (Figure 4.35). Mitochondrial clustering 
has been reported to occur prior to cytochrome c release (Haga et al., 
2003). Hence it is likely that aggregation of mitochondria is important 
for the intrinsic apoptosis by SARM. Thus, the ARM domain-mediated 





                            
Figure 4.35: SARM expression leads to mitochondrial clustering and 
aggregation. HEK 293T cells were transfected with SARM 234 GFP/ GFP, 
and the percentage of cells displaying mitochondrial aggregation/clustering 
phenotype was counted microscopically by staining the mitochondria with 
mitotracker. Data represent means ± SD of three independent experiments. 
*p<0.00005. 
 
4.6.4. The apoptotic effect of SARM is abolished in the absence of  
           SAM and TIR domains. 
Our findings shown in figure 4.18 indicate that the ST domain (SAM 
and TIR) is the proapoptotic functional domain of SARM. Currently, 
our data highlight that SARM is specifically localized in the 
mitochondria and that the mitochondrial localization of SARM is 
important for its proapoptotic phenotype (see figure 4.33). Thus it was 
imperative for us to test if the ST domain is important for apoptosis 
without affecting the mitochondrial localization of SARM. To support 





proapoptotic function of the mitochondria-targeting SARM, we 
compared the extent of cell death induced by SARM FL and SARM 234 
(lacking SAM and TIR domains). We showed that SARM 234 conferred 
a 5-fold drop in apoptosis when compared to the SARM FL (Figure 
4.36). This data strongly corroborate that the SAM and TIR domains 
are important for the proapoptotic function of the mitochondria-
associated SARM. 
                                                   
Figure 4.36: ST is the proapoptotic functional domain of SARM. HEK 293T 
cells were transfected with SARM FL and SARM 234. 24 h post-transfection, 
cell death was assessed by flow cytometry. Data represent means ± SD of 
three independent experiments. *p<0.00005. 
 
4.7. The biological importance of proapoptotic SARM in primary T  
        cells 
To appreciate the biological relevance of SARM, we studied the 





Furthermore we explored the effect of SARM knock down, during NID 
and AICD, which occur during T cell contraction. 
 
4.7.1. SARM expression is dynamically regulated during in vitro T  
           cell activation  
We studied the expression profile of SARM following activation of the 
primary cytotoxic T cells. We employed plate-bound anti-CD3 to 
mimic the infection-mediated activation of the cells. CD44 is a cell 
surface glycoprotein that is important for cell-cell interaction, cell 
adhesion and migration. CD44 expression is upregulated on T 
lymphocytes upon activation to promote their movement through the 
extracellular matrix (Dailey, 1998). Similarly, CD69 is a lectin protein 
that is an early marker of lymphocyte activation (Vilanova et al., 1996). 
Hence, we tested the expression of CD44 and CD69 on T cell activation 
by plate bound anti-CD3 treatment in vitro. Upregulation of CD44 and 
CD69 on days 1 and 2 post anti-CD3 treatment indicated successful 





       
Figure 4.37: Activation of CD8 T cells by anti-CD3 treatment. Primary CD8 
T cells were collected at 24 and 48 h post anti-CD3 treatment, and stained 
with activation markers: (A) CD44 and (B) CD69. Upregulation of CD44 and 
CD69 indicate the successful activation of the primary T cells. 
  
The endogenous level of SARM FL protein (~79 kDa) decreased 
rapidly post-activation, and recovered to above basal level from days 4 
to 8 (Figure 4.38A). Western blot also detected other fragments apart 
from the 79 kDa SARM FL protein, which warrants further 
characterization (discussed in section 5.6). CFSE labeling indicates that 
the anti-CD3 activated T cells underwent rapid proliferation post-
activation (Figure 4.38B). The SARM level dropped in the proliferating 
activated T cells. Additionally, pretreatment with a proteosome 
inhibitor, MG132, before T cell activation retained the expression of 





expression of SARM could be due to protein degradation (Figure 
4.38C). The increase in SARM FL protein in the activated T cells was 
accompanied by a gradual rise in the expression of Death receptor 
(FAS, CD95) and Death receptor ligand (FASL, CD95L), indicating the 
increased sensitivity to death (Figure 4.38D). Morphological 
observations suggest that on activation, the T cells expanded in size up 
to day 3, and rounded up by day 6 (Figure 4.38E). These observations 
were consistent with our aforementioned findings that SARM is 
implicated in T cell apoptosis. Hence, it is plausible that SARM 
accumulates sufficiently and becomes active after T cell activation, and 






Figure 4.38: SARM is dynamically regulated on T cell activation and 
proliferation. (A) Activated primary CD8 T cells were lysed on the indicated 
days post-activation and immunoblotted with anti-SARM. The membrane 
was stripped and reprobed with anti-actin. * Indicates the potential fragments 
of SARM. (B) CFSE-labeled naïve T cells were activated with plate-bound 
anti-CD3 and cell proliferation was studied by flow cytometry on days 1, 2, 3 
and 4 post-activation. (C) Primary T cells were pretreated with either 1 M 
MG132 or DMSO (-MG132, basal control) for 1 h and activated for 12 h in 
plate-bound anti-CD3. The cells were collected before and after T cell 
activation and immunoblotted with anti-SARM. Actin was used as a loading 
control. (D) Activated primary T cells were collected at indicated days and 
stained with PE-conjugated CD95 and CD95L, which are death receptor and 
death receptor ligand, respectively. Post-staining, the cells were washed and 
resuspended in FACS buffer and analyzed by flow cytometry. (E) Activated 
primary T cells were photographed daily for 8 days post-activation to follow 












Figure 4.39: SARM expression is downregulated during in vivo activation 
of T cells. OTI+ RAG-/-mice were subcutaneously injected with 5 g each of 
SIINFEKL peptide in complete Freund’s adjuvant. (A) Popliteal and inguinal 
lymph nodes were isolated and the cells were stained with CD69. Grey and 
black lines indicate cells from PBS injected control mice and SIINFEKL-
injected mice, respectively. (B) RNA was prepared and quantitative realtime 
PCR was carried out using mouse tubulin as endogenous control. (C) 
Enlarged popliteal and inguinal lymph node in the mice challenged with 
SIINFEKL peptide when compared to PBS injected mice. Black arrow points 
the location of the lymph nodes. Enlarged lymph nodes are marked in red 
circle. (D) Popliteal and inguinal lymph node cells isolated from PBS/ 
SIINFEKL injected mice were pooled and stained with trypan blue. The live 
cells are then counted using a Neubauer hemocytometer chamber. Data in (B) 
and (D) represent means of four mice per group. ***p<0.0005. 
 
To further study the kinetics of SARM expression in T cells activated in 
vivo, we challenged OTI+ RAG-/- mice with the SIINFEKL peptide (a 
peptide to which OTI transgenic TCR respond to). The peptide was 
administered by footpad injection and the corresponding enlarged 
draining lymph nodes, popliteal and inguinal lymph nodes, were 
collected on days 1 and 2 post-injection. Upregulation of CD69 was 
indicative of successful in vivo activation of OTI CD8 T cells (Figure 
4.39A). Consistently, we observed drastic reduction in the levels of 
SARM after T cell activation in vivo (Figure 4.39B). We observed 
enlarged popliteal and inguinal lymph node in SIINFEKL-injected 
mice when compared to PBS injected control (Figure 4.39C). 
Coincidently, we observed a significant increase in the cell number of 





challenged mice when compared to control mice (Figure 4.39D). 
Increase in cell number denotes activation-induced proliferation of T 
cells. Consistent with the in vitro experiment, the in vivo activation of T 
cells also suggests that cell proliferation is inversely related to the 
expression of proapoptotic SARM. 
 
The footpad injection had a severe impact on the movement of the 
mice. The mice appeared to suffer from severe pain and distress. Hence 
the experiment was terminated at a humane endpoint of 2 days based 
on IACUC (Institutional Animal Care and Use Committee) guidelines. 
 
4.7.3. Transient knockdown of SARM rescued T cells from NID 
To further confirm the proapoptotic functional role of SARM, we 
suppressed endogenous SARM in primary T cells ex vivo. Real time 
PCR and immunoblot analysis indicated up to 85% suppression of 
SARM mRNA and protein by SARM-specific siRNA (Figures 4.40A 
and B). Lymphocytes, when deprived of IL-2, a T cell growth factor, 
lose expression of anti-apoptotic proteins and die by neglect primarily 
via the mitochondrial pathway (Arnold et al., 2006; Brenner et al., 2008; 





Hence, by applying IL-2 deprivation, we mimicked NID that occurs 
during the T cell contraction phase (Gronski and Weinem, 2006). We 
observed that SARM knockdown dose-dependently rescued T cell 
death by up to 50% (Figure 4.40C), thus indicating that SARM plays a 
substantial role in apoptosis during T cell termination. 
 
Figure 4.40: Knockdown of SARM rescued CD8 T cells from NID. (A) NIH 
3T3 cells were transfected with SARM-specific siRNA or control siRNA. By 36 
h, the cells were collected and RNA was isolated. Quantitative realtime PCR 
was performed using mouse tubulin as endogenous control. NIH 3T3 cells 
were transfected with (B) SARM specific siRNA or control siRNA. The cell 
lysates were immunoblotted with anti-SARM. Actin was used as loading 
control. (C) 24 h post-nucleofection of primary T cells with increasing 
concentration of SARM-specific or control siRNA, the cells were deprived of 
IL-2. The cell death was measured 24 h post-deprivation. Data represent 












4.7.4. Stable knockdown of SARM prolonged T cell survival and  
          rescued them from AICD 
To further confirm the pro-survival effect on SARM knockdown, we 
stably suppressed endogenous SARM in primary T cells using 
retroviral transduction. Real time PCR and immunoblot analysis 
indicated that SARM-specific shRNA suppressed up to 85% 
suppression of SARM mRNA and protein levels (Figure 4.41A and B). 
We transduced activated primary T cells with pseudotyped retrovirus 
expressing SARM or non-targeting shRNA and GFP marker, and 
tracked the SARM knockdown and the non-targeting control cells for 
up to 9 days. We observed that SARM knockdown conferred ~50% 
increased survival of SARM knockdown CD8 T cells when compared 





       
Figure 4.41: Stable knockdown of SARM prolonged T cell survival and 
rescued them from AICD. NIH 3T3 cells were transfected with (A) either 
non-targeting control or SARM shRNA constructs (N1 and N3). By 36 h, the 
cells were collected and RNA was prepared. Quantitative realtime PCR was 
performed using mouse tubulin as control. NIH 3T3 cells were transfected 
with (B) non-targeting control or SARM shRNA constructs (N1 and N3). By 
36 h, the cells were lysed and lysates were immunoblotted with anti-SARM. 
Actin was used as a loading control. (C) Activated primary CD8 T cells were 
spinoculated with retrovirus containing either SARM-specific or non-
targeting control shRNA. The SARM knockdown cells were followed up to 
day 9 by counting the proportion of transduced GFP positive cells. Similar 
results were obtained in two other independent experiments. (D) Retroviral-
transduced cells were grown in the plate bound with anti-CD3 to induce 
activation-induced cell death. The cell death was measured 24 h post-






This result suggests that SARM knockdown effectively prolongs T cell 
survival. Lymphocytes undergo activation-induced cell death (AICD) 
during T cell contraction phase (Green et al., 2003). Thus, we mimicked 
AICD by restimulating the T cells with anti-CD3 and observed that T 
cells transduced with SARM-specific shRNA containing retrovirus 
showed significantly reduced cell death compared to the control 
(Figure 4.41D). 
 
4.8. SARM-knocked down T cells survive longer following influenza  
       infection  
To demonstrate the in vivo pathophysiological significance of SARM, 
we developed a novel adoptive transfer mouse model to follow SARM 
knocked down T cells during immune response against influenza 
infection (Figure 4.42). The endogenous T cells from SARM knockout 
mice are heterogenous and are anticipated to exhibit varied responses 
to an infection. Thus, we developed a more suitable mouse model for 
monitoring a cohort of CD8 T cells specific for the same epitope to 
study the effect of SARM knockdown during the shut-down of T cell 
immune response in an experimental infection with influenza virus. 
Primarily, we tested different stages of this model to ensure successful 






Figure 4.42: Schematic representation of the “adoptive transfer” in vivo 
mouse model to study the in vivo consequence of SARM knockdown 
during T cell immune response. Boxes indicated by dotted arrows highlight 
the key assessments that were performed to ensure efficient functioning of 
the developed model system.  
 
4.8.1. Successful activation of adoptively transferred OTI CD8 T cells  
          following influenza infection 
WSN SIINFEKL virus was obtained by infecting MDCK cell line and 
the virus was titrated as described in section 3.14.2. We obtained good 
viral titer of 7.5 X 104 PFU/ ml (Figure 4.43A). Initially, to test the 
efficacy of the in vivo influenza infection system, we adoptively 
transferred 5 x 105 naïve OTI CD8 T cells into Thy1.1 mice. The mice 
were then either infected or uninfected with 75 PFU of WSN SIINFEKL 
virus. Peak 2C T cell immune response was observed on 7 day post-





virus and naïve 2C CD8 T cells (Shen et al., 2008). Hence, we sacrificed 
the mice on 7 dpi. We observed OTI CD8 T cells only in the mediastinal 
lymph node (MLN) of the mice that were challenged with WSN 
SIINFEKL but not in the uninfected recipient mice (Figure 4.43B). OTI 
CD8 T cells in the MLN were activated as shown by the elevated 
expression of CD44 (Figure 4.43C). This data clearly demonstrate that 
the adoptively transferred OTI T cells underwent activation and 







                          
Figure 4.43: WSN SIINFEKL virus activated the OTI CD8 T cells in vivo. 
(A) WSN SIINFEKL virus cultured in MDCK cell line was titrated using 
plaque assay.  Crystal violet was used to visualize the plaques. The virus was 
serially diluted and the corresponding dilutions are specifically indicated 
above each of the wells. Naïve OTI CD8 T cells were adoptively transferred to 
Thy1.1 recipient mice. The mice were then infected with WSN SIINFEKL 
virus. (B) Thy1.2 positive OTI CD8 T cells in the mediastinal lymph node 
(MLN) of infected and uninfected recipient mice on 7 dpi. (C) Histogram of 
CD44 expression in Thy1.2 positive OTI CD8 T cells. Grey line corresponds to 
naïve OTI CD8 T cells from OTI+ RAG-/- mice and solid black line 
corresponds to OTI CD8 T cells from infected recipient mice. 
 
4.8.2. Successful development of in vitro memory T cells  
To study the effect of SARM knockdown during influenza infection in 





retroviral transduction system. The cells were then inclined to develop 
into memory T cells. The memory T cells were adoptively transferred 
and secondary infection was carried out in vivo using WSN SIINFEKL 
virus. Hence we primarily tested the ability to develop memory T cells 
in vitro. Naïve OTI CD8 T cells isolated from the OTI+ RAG-/- mice 
were activated in vitro using SIINFEKL peptide. Upregulation of CD44, 
CD69 and CD25 following SIINFEKL peptide treatment indicates 
successful activation of OTI CD8 T cells in vitro (Figure 4.44A). 
Similarly, culturing of activated T cells in the presence of IL-7 for more 
than two weeks resulted in the upregulation of memory T cell markers, 
CCR7 and CD62L (Figure 4.44B). The upregulation of these markers 







Figure 4.44: Successful development of in vitro memory T cells. (A) Primary 
T cells were activated with 1 g of SIINFEKL peptide and the cells were 
stained with activation markers (CD69, CD44 and CD25) on days 0 and 2 
post-activation. Post-staining, the cells were washed and resuspended in 
FACS buffer and analyzed by flow cytometry. Black line corresponds to in 
vitro activated primary T cells and grey line corresponds to naïve primary T 
cells. (B) Activated OTI CD8 T cells were cultured in the presence of IL-7 for 
more than two weeks to develop into memory T cells. The memory 
phenotype was verified by staining with CCR7 and CD62L. Grey line 
corresponds to naive and activated T cells in CCR7 and CD62L staining, 









 4.8.3. T cell immune response is maximal on 5 dpi 
To investigate the dynamics of T cell response to influenza infection, 
we adoptively transferred in vitro developed memory OTI CD8 T cells 
into Thy1.1 congenic mice and challenged the mice with WSN 
SIINFEKL virus. We measured the percentage of OTI CD8 T cells in 
mediastinal lymph node (MLN), peripheral lymph node (PLN) and 
spleen from 3 to 14 days post-infection (dpi). Lung draining MLN 
harbored a greater proportion of OTI CD8 T cells when compared to 
the PLN and spleen. The peak in T cell response occurred on 5 dpi 
where ~ 2.2 % of cells in the MLN were OTI CD8 T cells. By 7, 10 and 
14 dpi, the OTI T cells contracted to 0.49%, 0.68% and 0.01%, 
respectively (Figure 4.45).  Collectively, these results suggest that an 
efficient system has been developed to study the role of SARM during 
OTI T cell response to influenza infection. 
 
Thus, we have developed a suitable model to study the effect of SARM 











Figure 4.45: T cell proliferation is maximal at 5 dpi. (A) OTI CD8 T cells in 
mediastinal lymph node (MLN), peripheral lymph node (PLN) and spleen of 
infected recipient mice at various dpi. The Thy1.2 vs CD8 profile was gated 
based on all live cells in the indicated tissues. 
 
 
4.8.4. SARM-knocked down T cells expanded more than control    
           following influenza infection    
To investigate the proapoptotic functional role of SARM during/after 
an influenza infection, we transduced the SIINFEKL-activated OTI 
CD8 T cells with retrovirus expressing SARM-specific shRNA or non-
targeting control shRNA with GFP reporter. The T cells were then 
inclined to develop into in vitro memory T cells. Immunoblot analysis 
indicated a significant reduction in the levels of SARM in the 
knockdown memory T cells when compared to the control (Figure 
4.46A). Either SARM-knocked down (~ 20% GFP+ transduced cells) or 
control (~ 10% GFP+ transduced cells) memory T cells were adoptively 
transferred to the Thy1.1 congenic mice. The mice were then 
challenged with WSN SIINFEKL virus. The proportion of OTI T cells 
positively transduced with GFP was analyzed in MLN on 3, 5, 7 and 10 
dpi corresponding to the activation (3 dpi), peak response (5 dpi) and 
contraction phase (7 and 10 dpi) of T cell immune response (see figure 
4.45). Non-targeting control-transduced T cells gradually expanded 





contracted back to 14% by 10 dpi (Figure 4.46B). Interestingly, SARM-
specific shRNA transduced T cells expanded from 20% to 40% by 5 dpi 
and continue to expand to 56% by 7 dpi and then contract to 40% by 10 
dpi (Figure 4.46B). Thus by day 7 following influenza infection, SARM-
knocked down T cells increase significantly compared to non-targeting 
control T cells. By 10 dpi, SARM knockdown T cells also start to 
contract due the role of other proapoptotic players involved in T cell 
contraction, compensating the absence of SARM. This in vivo data 
further support the proapoptotic functional role of SARM during T cell 









Figure 4.46: SARM knockdown T cells expanded more than control 
following influenza infection. (A) Lysates from retroviral transduced in vitro 
memory T cells (non-targeting control and SARM-specific shRNA) were 
collected and immunoblotted with anti-SARM. The same membrane was 
reprobed with anti-actin for loading control. (B) The proportion of GFP 
positive non-targeting shRNA or SARM-specific shRNA expressing OTI CD8 
T cells in MLN of infected recipient mice on various dpi. Data represent the 
means of results from 4 recipient mice. *p<0.0007; NS; non-significant. 
 
4.9. SARM is downregulated in NK/T cell lymphoma biopsy tissues 
Apoptosis of activated T cells after successful eradication of the 
infectious pathogen is important for the shutdown of T cell immune 
response. Failure of this results in a concomitant risk of developing 
leukemia/lymphoma or autoimmune disease. Hence, we examined 
whether and how the levels of proapototic SARM might be altered in 





    
Figure 4.47: SARM is downregulated in NK/T cell lymphoma patient’s 
biopsy tissues. RNA was extracted either from FFPE patient extranodal 
tissues (n=6) or normal NK cells (n=2) or IL-2 stimulated normal NK cells 
(n=2) or NK/T cell lymphoma cell lines (n=6). cDNA, reverse-transcribed 
from RNA was used as template for realtime PCR and data were normalized 
to human GAPDH. Relative quantification (RQ) of SARM expression (A) 
between normal NK cells, stimulated NK cells and NK/T cell lymphoma 
tissue and (B) between normal NK cells and NK/T cell lymphoma derived 
cell lines. Each sample is represented by a triangle and the mean of each 
group is indicated by red line. *p<0.005; **p<0.0005. 
 
NK/T cell lymphoma, with the cytotoxic phenotype, is the most 
prevalent form of lymphoma in Asia. Global comparative gene 
expression profile indicated that SARM is downregulated in NK/T 
lymphoma tissues when compared to healthy cells (Ng et al., 2011). 
Hence, we studied the expression of SARM in the biopsy tissues of 
NK/T cell lymphoma patients. A 9-fold decreased expression of SARM 





normal NK cells (Figure 4.47A). Coincidently, we found that normal 
NK cells stimulated with IL-2 also expressed lesser SARM than 
untreated NK cells (Figure 4.47A). NK/T lymphoma cells and normal 
NK cells stimulated with IL-2 proliferated significantly rapidly than 
untreated cells. Hence, it is evident that decrease in the expression of 
SARM supports NK/T cell proliferation. Further analysis with NK/T 
cell lymphoma derived cell lines also showed lower levels of SARM 
compared to normal NK cells (Figure 4.47B). Taken together, since 
SARM is proapoptotic, its lowered expression is probably linked to the 

















5.1. SARM is a unique TLR adaptor protein 
In evolutionary terms, SARM is a well-conserved TLR adaptor from 
worms to human. Unlike other TLR adaptors, SARM is not highly 
expressed in the myeloid lineage (Kim et al., 2007). The prominent 
contribution of other TLR adaptors (MyD88, TRIF, MAL and TRAM) to 
TLR signaling is well documented and this fueled the expectation that 
SARM would play a similarly significant role. However, the C. elegans 
SARM homologue, TIR-1, is reported to function independently of TLR 
(Couillault et al., 2004). Although, in vitro studies highlighted SARM to 
be a negative regulator of TLR signaling (Carty et al., 2006; Peng et al., 
2010), the data from SARM knockout mice indicated that SARM does 
not play a role in regulating macrophage TLR signaling (Kim et al., 
2007; Szretter et al., 2009). Thus, the role of SARM in TLR signaling has 
been questionable, and evidently SARM is a unique TLR adaptor that 
is not yet fully understood. 
 
5.2. Mitochondrial localization of SARM  
Earlier studies had reported that SARM associates to the outer 





typical mitochondria targeting signal, the ARM domain of SARM was 
considered to be important for this association (Kim et al., 2007; Yuan et 
al., 2010). Moreover, it is shown that transient expression of SARM GFP 
appeared as dots in the nucleus and elsewhere in the cell (Peng et al., 
2010). Therefore, the precise localization of SARM in relation to its 
cellular function has hitherto been unclear. In this study we 
demonstrate the mitochondria-targeting ability of the most conserved 
TLR adaptor, SARM, by immunofluorescence, Western blot and 
transmission electron microscopy (Section 4.2) (Panneerselvam et al., 
2012a). Furthermore, we delineated the mitochondria-targeting ability 
of SARM to its N-terminal signal sequence and showed that the N-
termini sequences are well conserved across various SARM 
homologues (Section 4.3). Importantly, the presence of a mitochondria-
targeting signal sequence in SARM reflects its biological significance 
and helps to explain how SARM might mediate apoptosis in neurons, 
T cells and in the C. elegans (Hayakawa et al., 2011; Kim et al., 2007; 
Panneerselvam, 2012b). 
 
There is no sequence similarity between S27 and other known 





structural features of hydrophobicity, positively charged residues and 
alpha helicity, which are important for targeting the mitochondria 
(Figure 4.10). Nevertheless, it is important to note that the alpha helix 
in the S27 lacks amphiphilicity, which is purportedly critical for 
binding to the mitochondria import machinery (Figure 4.10) (von 
Heijne, 1986). However, our results suggest that the hydrophobic and 
the conserved polybasic residues serve as a bipartite signal and are 
sufficient to target the mitochondria. We further showed evidence that 
the S27 peptide has an inherent ability to interact with lipids (Figure 
4.11), which might facilitate its import into the mitochondria. In 
addition, TEM indicated that S27 is able to translocate EGFP into the 
mitochondria. Further confirmation was obtained by double 
immunogold labeling of S27 EGFP with mitochondrial matrix targeting 
protein PDH E1 (Figure 4.13). Interestingly, the mitochondria-
targeting ability of S27 was abolished when S27 was cloned 
downstream of the EGFP reporter, indicating that the S27 is only 
functional as a mitochondrial target when it is at the leading end of the 
protein (Figure 4.12). The mitochondria-targeting ability of SARM was 
further supported by Western blot analysis of mitochondrial fraction 





Since, the positively charged amino acids in a signal sequence are 
earlier documented to be important for the transport across the 
membrane via the TOM/TIM import machinery (Bauer et al., 2000; 
Bauer et al., 1996; Komiya et al., 1998; Neve and Ingelman-Sundberg, 
2001), we mutated all four positively charged amino acids to 
uncharged Alanine. Surprisingly, only the Arg14Ala mutant effectively 
abolished the mitochondrial targeting ability of S27 (Figure 4.14). The 
ability of Arg14 in determining the mitochondrial localization was 
confirmed using another cell line, NIH 3T3 (Figure 4.14). 
Coincidentally, Arginine23 in the mitochondria signal sequence of 
ornithine transcarbamylase was also reported to be very critical for 
import (Horwich et al., 1986). On the contrary, the mitochondria-
targeting ability of cytochrome P450 2E1 and aldehyde dehydrogenase 
was abrogated only when at least two or all of the Arginine residues at 
the leader sequences were mutated simultaneously (Hammen and 
Weiner, 1998; Neve and Ingelman-Sundberg, 2001). Thus, Arginine 
appears to be the common critical determinant for the interaction with 
either the mitochondria import machinery or directly with the 






Importantly, mutating Arginine 14 to Alanine caused SARM to lose 
50% of its apoptotic potential (Figure 4.33). This clearly shows that the 
mitochondrial localization of SARM is important for its proapoptotic 
activity. However, the proapoptotic potential of Arg14Ala mutant was 
not completely abolished, suggesting the contribution of other residues 
and/or existence of other factors that are important for the full 
proapoptotic potential of SARM. 
 
We also showed that SARM expression altered the distribution of 
mitochondria, causing them to cluster (Section 4.6.3). Mitochondrial 
clustering has also been observed in TNF-, TRAIL-, FASL- and 
oxidative stress- induced cell death (Aslan and Thomas, 2009). SARM 
was reported to co-sediment with polymerized microtubule (Kim et al., 
2007). Another independent study highlighted that SARM participate 
in the microtubule stability of the cell (Chen et al., 2011). Hence, it is 
likely that SARM regulate the mitochondrial traffic in microtubule. 
SARM is also reported to interact with kinase JNK3 (Kim et al., 2007). 
JNK-3 is known to phosphorylate a microtubule-associated protein 
named tau, and phosphorylation of tau is reported to regulate 





Hence, further studies are required to determine detailed mechanism 
enabling mitochondrial clustering. It is known that mitochondrial 
clustering occur prior to cytochrome c release (Haga et al., 2003). 
Hence, it is likely that the aggregation of mitochondria is important for 
intrinsic apoptosis mediated by SARM. 
 
5.3. Proapoptotic phenotype exhibited by SARM   
Although, it is well established that apoptosis of activated T cells 
restores homeostasis, the precise underlying mechanisms have hitherto 
been elusive. In mammals, SARM is hypothesized to be a common 
regulator of neuronal and immune response to danger (Dalod, 2007). 
Here, for the first time, we demonstrated that SARM is localized in the 
mitochondria and it mediates intrinsic apoptosis in cytotoxic T cells to 
maintain T cell counts during T cell contraction.  
 
SARM expression also exhibited proapoptotic phenotype in different 
cell types like neurons, NK cells and B cells (Figure 4.22). Consistently, 
previous study using SARM knockout mice indicated that SARM is 
important for neuronal survival (Kim et al., 2007). The SARM 





(Hayakawa et al., 2011). Thus it appears that the proapoptotic function 
of SARM is evolutionarily conserved from C. elegans to human. 
Importantly, the proapoptotic role of SARM is not limited to T cells. 
 
5.4. In vivo adoptive transfer mouse model 
To prove the pathophysiological importance of the proapoptotic role of 
SARM during T cell contraction, we developed a novel “adoptive 
transfer mouse model” system. Our model system has several 
advantages when compared to following the T cell immune response 
in SARM knockout mice (Table 5.1). This novel system is an important 
innovation, which could become useful for other future researchers. 
 
We tracked SARM knockdown T cells on 3, 5, 7 and 10 dpi, which 
correspond to the activation (3 dpi), the peak of response (5 dpi) and 
the contraction (7 and 10 dpi) phases of T cells. Notably, SARM-
knocked down T cells expanded more than the control T cells during 
the T cell contraction (Figure 4.46), clearly supporting the 
pathophysiological role of SARM in vivo. Failure in T cell contraction 
causes autoimmunity and lymphoproliferative diseases like lymphoma 





Coincidentally, NK/T cell lymphoma patient’s biopsy tissues have 
lower levels of proapoptotic SARM when compared to healthy cells 
(Figure 4.47). 
 
Table 5.1: Advantages of “adoptive transfer mouse model system” over  
                  SARM knockout mice 
 
                            
 
 
5.5. Mechanistic action of SARM  
Importantly, SARM expression significantly reduced the level of 
proapoptotic Bcl-xL (Figure 4.28). BAX and BAK are the key effectors 
of Bcl-2 family that are involved in MOMP formation (Chipuk et al., 
2012; Kuwana et al., 2002). Bcl-xL is reported to retrotranslocate 
proapoptotic BAX from mitochondrial outer membrane to the 





MOMP formation (Edlich et al., 2011) that releases cytotoxic proteins 
like cytochrome c and Apoptosis Inducing Factor (Kroemer et al., 2007). 
Overexpression of Bcl-xL has been reported to inhibit apoptosis by 
suppressing the generation of ROS and preventing MPTP and release 
of cytochrome c (Cory et al., 2003; Reed, 1998). Consistently, the 
overexpression of Bcl-xL and BAX BAK double knockout resulted in a 
significant reduction in SARM-induced apoptosis (Figures 4.29 and 
4.30). Hence, it is likely that SARM-induces MPTP via Bcl-2 family 
(Figure 5.1). It is important to note that BAX-/-BAK-/- chimera mice 
develop splenomegaly and lymphadenopathy highlighting the 
importance of intrinsic apoptosis during T cell immune response 







Figure 5.1. The conceptual link between SARM and Bcl-2 family. Panel 1: In 
healthy cells, Bcl-xL is known to translocate BAX from mitochondria outer 
membrane (MOM) to cytosol, thus preventing MOMP formation (Edlich et al., 
2011). Panel 2: Bcl-xL levels are reduced during SARM-induced apoptosis 
and thus BAX is free to homo-oligomerize to form MOMP. Panel 3: Bcl-xL 
overexpression prevents SARM-induced apoptosis and BAX BAK double 
knockout abrogates MPTP-induced by SARM. Both these data support that 
SARM mediates intrinsic apoptosis via Bcl-2 family members. 
 
MPTP is followed by the release of cytotoxic proteins like Cytochrome 
c and Apoptosis Inducing Factor (Kroemer et al., 2007). Thus, MPTP 
induced by SARM led to the activation of the cascade of caspases-9, -3 
and -8 (Figure 4.25). Caspase-9 and caspase-8 are the two major 
initiator caspases that became activated during T cell contraction 





important cellular proteins resulting in cell shrinkage, chromatin 
condensation and nuclear breakdown (Figure 4.19). 
 
ERK is a key transcription factor that signals cell proliferation and 
survival (Zhang and Liu, 2002). We found that SARM expression 
downregulated the phosphorylation of ERK (Figure 4.32), inhibiting 
the survival signal. ERK MAPK has been earlier reported to inhibit 
caspase-9 activity through phosphorylation (Allan et al., 2003). Hence, 
it is likely that the downregulation of ERK contributes to the increased 
caspase activity. While dephosphorylation targets Bcl-2 for ubiquitin-
dependent degradation (Dimmeler et al., 1999), ERK-mediated Bcl-2 
phosphorylation stabilizes it (Breitschopf et al., 2000). Furthermore, 
TNF (a proapoptotic stimulus) deactivates ERK thus inducing 
degradation of Bcl-2 leading to apoptosis (Breitschopf et al., 2000). 
Similarly, the observed downregulation of pERK by SARM, could 
possibly affect the phosphorylation of Bcl-xL leading to its degradation 






Figure 5.2. Model for downregulation of Bcl-xL by SARM. Phosphorylation 
of Bcl-xL might be affected by the downregulation of pERK by SARM. 
Dephosphorylation of Bcl-xL might compromise the stability of Bcl-xL 
leading to its degradation. Thus proapoptotic BAX is free to oligomerize on 
the mitochondrial outer membrane leading to MOMP formation. 
 
Immediately post-activation of T cells, the expression of SARM 
drastically fell and then rose as the levels of FAS and FASL increases. 
FAS and FASL are reported to play a key role in maintaining T cell 
homeostasis (Krammer, 2000). Naturally occurring mutations in the 
death receptor FAS (lpr allele) or its ligand, FASL (gld) results in 
autoimmunity and lymphoproliferation in mice as the extrinsic 
apoptotic pathway is blocked (Nagata and Suda, 1995; Watanabe-
Fukunaga et al., 1992). Our data highlight that increased SARM 
expression significantly reduces the levels of anti-apoptotic protein, 
Bcl-xL (Figure 4.28). The major checkpoint in the execution of cell 
death pathway is the ratio of pro-apoptotic to anti-apoptotic Bcl-2 





of SARM has an inverse relationship with cell proliferation. SARM 
mRNA levels drastically drop during activation induced proliferation 
of both cytotoxic T and NK cells (Figures 4.38 and 4.47A). A similar 
drop in the level of SARM was observed in T cells proliferating in vivo 
(Figure 4.39). Consistently, expression of SARM is reduced in actively 
proliferating NK/T cell lymphoma biopsy tissues when compared to 
healthy cells (Figure 4.47). Hence, it is likely that differential expression 
of SARM during T cell activation, proliferation and contraction 
modulate its proapoptotic function. 
 
NID and AICD are the two major modes of cell death that occur during 
T cell contraction (Krammer et al., 2007). Hence, we tested the effect of 
SARM knockdown during NID and AICD. Although SARM-knocked 
down T cells had significantly decreased NID and AICD (Figures 4.40 
and 4.41), it did not completely abolish these death pathways, 
indicating that other pathways are simultaneously operational. At this 
juncture, it is important to note that although SARM primarily acts via 
intrinsic pathway, it also activates caspase-8, the initiator caspase of 





unidentified molecular targets apart from Bcl-xL, to mediate its 
apoptotic function effectively.  
 
The proapoptotic function of SARM is mapped to the SAM and TIR 
domains at the C-terminus (Figures 4.18 and 4.36). The ST domains 
were also determined to be the functional domains in down regulating 
TLR signaling (Belinda et al., 2008; Carty et al., 2006; Peng et al., 2010). 
Coincidently, the C. elegans Tir-1, when truncated to only the two SAM 
and TIR domains, exhibited stronger gain-of-function in its neuron 
development phenotype than the full-length protein (Chuang and 
Bargmann, 2005). Thus, it appears that the SAM and TIR domains at 
the C terminus of SARM are the key functional domains. Taken 
together we have precisely mapped the key role of various domains of 







        
Figure 5.3: Functional significance of various domains of SARM. The S27 is 
the mitochondria targeting signal sequence of SARM. While the ARM 
domain is important for mitochondrial clustering and polarization, the SAM 
and TIR domains are important for the proapoptotic function of SARM. 
 
5.6. Does SARM undergo cleavage to become activated? 
Apoptosis induced by SARM FL and SARM ST (SAM and TIR 
domains) occurs consistently in HEK 293T (Figure 4.18), Raji B (Figure 
4.22D) and NK-YS (Figure 4.22E) cells. However, in CD8 T cells (Figure 
4.21) and Neuro-2a (Figure 4.22B) cells, SARM ST-induced cell death is 
higher than SARM FL itself. SARM ST and SARM AST constructs, 
which are devoid of the mitochondria-targeting sequence, are able to 
induce apoptosis. Hence, we examined the possibility of SARM to 







Immunoblot analysis of activated CD8 T cells with SARM-specific 
antibody raised against the C-terminus showed additional fragments 
of 65 and 37 kDa. Their expression level accumulates following T cell 
activation - the 65-kDa fragment increased up to 3 days and the 37-kDa 
fragment was sustained until day 8 (Figure 4.38A). To further 
understand how these SARM fragments might be mechanistically 
linked to T cell apoptosis, we stained the cells with Annexin V and 7-
AAD on days 3 and 8 following activation, and sorted three major 
populations – (1) Double-negative healthy cells (H), (2) Annexin V-
positive and 7-AAD-negative early apoptotic cells (EA) and (3) 
Annexin V- and 7-AAD-double positive late apoptotic cells (LA). We 
found that both the early and late apoptotic cells only expressed the 65-
kDa fragment (Figure 5.4A), suggesting that this fragment might be 
directly linked to T cell apoptosis.  
 
As the antibody is targeted to the C-terminal region, these 65 and 37 
kDa fragments are consistent with the molecular size of SARM AST 
and SARM ST, respectively, which our above findings showed that 





accumulation of SARM AST and SARM ST upon T cell activation was 
likely to positively influence T cell apoptosis. 
            
Figure 5.4: Putative SARM fragment is enriched during T cell death. (A) On 
days 3 and 8 post-activation, the T cells were sorted based on Annexin V 
FITC and 7-AAD staining. The sorted cells were immunoblotted with anti-
SARM. The membrane was stripped and reprobed with anti-actin. H denotes 
double negative “healthy” cells, EA represents “early apoptotic” Annexin V-
positive and 7-AAD-negative cells, and LA indicates “late apoptotic” double 
positive cells. # and ‡ correspond to days 3 and 8 post-activation of T cells, 
respectively. (B) Schematic representation of observed cleavage fragments of 
SARM based on the molecular weight and anti-SARM recognition epitope.   
 
ExPASy predicted a caspase-1 cleavage site in SARM. Hence we tested 
the potential cleavage of in vitro transcribed-and-translated (TNT) 
SARM using recombinant caspase-1. However, we did not detect the 





formation of these fragments by treatment with a caspase-1 specific 
inhibitor (z-WEHD FMK) and a general caspase inhibitor (z-VAD 
FMK), but failed to notice any difference (Figures 5.5B), suggesting 
that SARM cleavage is probably executed by factors other than the 
caspases-mediated pathways. Thus, cleavage of SARM is more 
complex than anticipated. Further analyses are necessary to elucidate 
the sequential cleavage events, the cleavage site(s), and the potential 






                        
Figure 5.5: Does caspase-1 cleave SARM? (A) Recombinant SARM was 
obtained by in vitro transcription and translation of the pCDNA-SARM 
construct by following the manufacturer’s instructions. The rSARM was then 
incubated with the indicated Units of caspase-1 at 37C. The lysates were then 
analyzed by Western blot using anti-SARM. In vitro transcribed-and-
translated recombinant SARM was smaller in size than the endogenous 
SARM as it lacked the post-translational modifications like N-glycosylation, 
phosphorylation and palmitoylation that are predicted to occur in 
endogenous SARM. (B) Primary CD8 T cells were pretreated with caspase-1 
inhibitor (z-WEHD FMK) and general caspase inhibitor (z-VAD FMK). The 
cells were then activated with anti-CD3. At 12 h post-activation, cell lysate 
was prepared and analyzed by Western blot using anti-SARM. The same 






5.7. Broad implications of the study  
Of all the TLR adaptors, SARM is most well-conserved but the least 
understood. Conservation of SARM from C. elegans to human implies 
that SARM plays a crucial role in species survival. Although, SARM is 
relatively highly expressed in T cells, this is the pioneer study that 
defines the functional role of SARM in T cells. It is important that the 
activated and expanded populations of T cells should be removed from 
the system following the clearance of the infection. Most of the studies 
have focused only on how T cells become activated, but how the 
system returns to normal remains an enigma. The homeostatic control 
and regulation of T cells is a very interesting biological question to 
explore. We showed that the purported TLR adaptor, SARM is 
involved in maintaining normal T cell counts after clearance of 
infection. This thesis describes our effort in studying on how SARM is 
involved in apoptosis and how T cell homeostasis would help in 
understanding its potential role in modulating the immune system to 
clear the pathogen as well as protect the host from immune-
overreaction, inflammation and cancer.  Knowledge gained from this 
research can potentially be used in further research for the treatment of 





including lymphopenic disorders such as immunodeficiencies and 
lymphoproliferative disorders such as lymphomas and autoimmune 
diseases.   
 
Currently, drugs are being developed to target antioxidants or 
membrane-disrupting agents to the mitochondria as a therapy for 
various oxidative stress-related diseases and tumors (Anders et al., 
2006; Ellerby et al., 1999; Rocha et al., 2010; Sheu et al., 2006; Szewczyk 
and Wojtczak, 2002). Our study has precisely delineated the 
mitochondria-targeting signal sequence in SARM. The knowledge 
gained in this study may lead to the design of therapeutics to 














Of immune related cells, SARM is reported to be expressed in 
lymphocytes and more specifically in cytotoxic T cells (Dalod, 2007). 
Hence, it was assumed that SARM might contribute to T cell 
immunity. For the very first time we have studied the functional 
significance of SARM in T cells. We have proven our hypothesis - 
“Mitochondrial localized SARM activates apoptotic signal to maintain 
T cell homeostasis following clearance of infection” through our three 








Figure 6.1: Overview of the three specific aims and key findings that prove  
                   the hypothesis 
 
In conclusion, our study has shown how SARM is involved in 
terminating the activated T cells via intrinsic apoptosis. Interestingly, 
we found that SARM-expressing cells exhibited hallmarks of 





nuclear fragmentation. Our study, for the very first time, has clearly 
demonstrated the mitochondria-targeting ability of SARM by 
immunofluorescence, Western blot and transmission electron 
microscopy. Furthermore, we have isolated the crucial mitochondria 
targeting sequence and identified the single residue, Arginine14, which 
determines the mitochondria-targeting specificity. Concomitant to the 
mutation of Arg14 was a substantial reduction in the apoptotic 
potential of SARM. Thus, the mitochondria-targeting characteristic of 
SARM reflects its biological importance in mediating apoptosis in 
neurons, T cells and in the C. elegans. We have provided compelling 
evidence that mitochondria-localized SARM perturbs the 
mitochondrial integrity and causes mitochondrial clustering. SARM 
mediates intrinsic apoptosis by altering the levels of Bcl-xL, and 
blocking the cell survival mediator, ERK. In addition, SARM 
expression also resulted in increase in intracellular reactive oxygen 
species. Consistently, Bcl-xL expression and BAX BAK double 
knockout significantly hampered SARM-induced apoptosis further 
confirming the intrinsic apoptotic pathway mediated by SARM. 
Importantly, we have mapped the proapoptotic function of SARM to 





knocked down cells showed reduced apoptosis during both neglect- 
and activation- induced cell death (NID and AICD). We recapitulated 
the physiological significance of SARM-induced apoptosis during T 
cell contraction following an influenza infection in our “adoptive 
transfer” mouse model system. Collectively, we demonstrated how a 
decrease in SARM expression correlates with actively proliferating 
NK/T cell lymphoma tissues and that accumulation of SARM caused 
the proliferating T cells to die by intrinsic apoptosis. Similar decrease 
in SARM expression on cell proliferation was confirmed in T cells 
actively proliferating in vivo. Significantly, we highlight that 
proapoptotic effect of SARM is not just limited to T cells (Figure 6.2). 
 
These novel findings provide a new dimension in the understanding of 
the potential role of SARM, previously purported to be just another 
TLR adaptor. In fact, SARM helps to maintain the T cell count during T 
cell contraction. Interestingly, we are a step closer to understanding 
how to develop suitable molecular therapy for lymphoproliferative 








Figure 6.2: A model to illustrate the proapoptotic potential of SARM during 
T cell immune response. Antigen presenting cells (APC) present the epitopes 
of the foreign pathogens to the T cells. Antigen-specific T cells undergo clonal 
expansion and differentiate into effector T cells. These T cells help in the 
pathogen clearance. Later, apoptosis specifically contracts the expanded T 
cells in a well-orchestrated manner. Our influenza infection mouse model 
demonstrates the proapoptotic function of SARM during T cell immune 
response. SARM expression is significantly decreased during activation-
induced T cell clonal expansion to support proliferation. During T cell 
contraction, SARM is elevated and it acts proapoptotically via intrinsic 
pathway. SARM seems to oppose the survival signal mediated by ERK 
phosphorylation, and also modulates the levels of the antiapoptotic Bcl-xL, 
leading to the loss of mitochondrial integrity. The release of the 
mitochondrial content leads to activation of the initiator caspase-9 and 
effector caspase-3. Activated caspases lead to apoptosis, thereby bringing 
down the number of T cells. Failure of T cell contraction may result in 
lymphoproliferative diseases and autoimmunity. Coincidently, the 
expression of proapoptotic SARM is reduced in NK/T lymphoma tissues 








7. Future Perspectives 
Based on the findings in this thesis, there are several interesting 
questions that can be addressed in future to further characterize the 
functional significance of SARM. 
 
7.1. How is SARM imported into the mitochondria? 
Although our data show that S27 has a direct ability to bind to 
membrane phospholipids, some other proteins are probably required 
to transport SARM protein into the mitochondria. Hence, it will be 
interesting to examine whether SARM follows the classical 
mitochondrial import mechanism via TOM/TIM import machinery. 
There should be a cytosolic chaperone that guides SARM to the 
mitochondrial import machinery. It will be exciting to identify 
molecular target(s) on the mitochondria to which the SARM 
docks/interacts with.  It is also motivating to determine the exact 
domain of SARM that interacts with the TOM/ TIM import machinery. 
Arginine was reported to be very critical for import in several 
mitochondria signal sequence of ornithine transcarbamylase, (Horwich 





2001). This might help to answer why the Arginine at 14th position is 
critical in determining the mitochondrial localization of SARM.  
 
7.2. Are there novel interaction partners of SARM which facilitate  
        apoptosis? 
 
Unlike other TLR adaptors, SARM possesses a unique domain 
architecture comprising three major domains (two ARM, two SAM and 
one TIR) that are reported to be involved in protein-protein 
interactions. Although, several interaction partners were reported for 
mammalian SARM in the brain and retina (Belinda et al., 2008; Chen et 
al., 2011; Kim et al., 2007; Molday et al., 2007), there is no report on any 
interaction partner(s) of SARM in immune cells. It will be interesting to 
perform yeast 2-hybrid screening to determine interacting partners of 
SARM in cDNA library of immune cells. This might provide additional 
insights to the function of SARM. Our study indicated that neither Bcl-
xL nor Bcl-2 interacts with SARM. SARM could probably mediate 
apoptosis by interacting with other apoptotic mediators.  
 
7.3. How does SARM mediate mitochondrial clustering? 
Our findings affirm that SARM mediate mitochondrial clustering. It 





mitochondrial polarization. It is necessary to test how SARM 
modulates the trafficking of mitochondria. Several conditions like TNF 
 treatment and hyperphosphorylation of tau are reported to cause 
mitochondrial clustering (Tatebayashi et al., 2004). It will be interesting 
to check whether SARM is involved in these processes. UXT and -
actin are reported to mediate mitochondrial clustering (Li et al., 2004; 
Moss et al., 2007). Hence, it will be interesting to test if SARM interacts 
with these proteins. This thesis has shown that the ARM domain is 
important for mitochondrial clustering and polarization. Hence it is 
likely that the ARM domain interacts with the above stated proteins. It 
would be useful to employ the ARM subclones to verify such potential 
interactions. 
 
7.4. Is SARM cleaved during apoptosis? 
It is still not very clear if SARM undergoes cleavage to release 
functional fragments. Similar to the observations made in this work, 
Peng et al also observed some fragments of SARM when the U937 cells 
were treated with LPS (Peng et al., 2010). TLR adaptors and several 
apoptotic mediators are reported to undergo cleavage (Miggin et al., 





required to raise specific monoclonal antibodies against both the N and 
C termini of SARM.  One other possibility is to construct a SARM clone 
tagged with two different tags at the N and C termini. In such case 
antibodies against the two tags can be used to study the specific 
cleavage events (Figure 7.1). 
 
Figure 7.1. Pictorial representation of double tagged SARM. Both the N and 
C termini of SARM can be tagged with two different tags. Monoclonal 
antibodies against each of the tags can be used to follow the cleavage events. 
 
We should primarily test for specific cleavage events of SARM during 
infection-induced apoptosis. After confirming the cleavage and 
processing of SARM, we can delineate the specific protease/proteases 
involved. This is quite challenging but the effort will unravel the 
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